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The Rockefeller University 2014 
 
Activation-induced cytidine deaminase (AID) is essential for two 
processes of immunoglobulin diversification in germinal center B cells: somatic 
hypermutation (SHM), in which mutations are introduced into immunoglobulin 
(Ig) genes, and class-switch recombination (CSR), in which genomic constant 
regions are recombined to encode antibodies of different isotypes. Both of these 
processes require AID-catalyzed C-to-U lesions at the Ig loci, which are resolved 
to generate point mutations or double-stranded DNA breaks in the cases of SHM 
and CSR, respectively. Despite over a decade of intense study, a number of open 
issues remain surrounding AID. The diversity of findings regarding AID’s role in 
DNA demethylation raises the question of the scope of its involvement in this 
process. Additionally, while it is clear that AID-mediated damage occurs, the 
effects of this damage on the average B cell have not been characterized. Finally, 
the issue of whether AID is able to edit RNA in vivo has never been rigorously 
addressed in the literature. 
 In each of these cases, the advent of high-throughput sequencing provides 
methods for genome-wide characterization of AID’s effects. This thesis presents 
the application of a number of genome-scale, sequencing-based methods to 
characterize the effects of AID deficiency and overexpression on the activated B 
cell: mRNA-Seq and miRNA-Seq allow for measurements of RNA expression 
and editing, while reduced-representation bisulfite sequencing (RRBS) assays 
DNA methylation. These analyses confirmed AID’s known role in 
immunoglobulin isotype switching, while also demonstrating that it has little 
other effect on gene expression. Additionally, no evidence of AID-dependent 
mRNA or miRNA editing could be detected. Finally, RRBS data failed to support 
a role for AID in the regulation of DNA methylation. Thus, despite evidence of 
its additional activities in other systems, antibody diversification appears to be 
AID’s sole physiological function in activated B cells. 
Following the conclusion of my studies of AID’s effects in B cells, I 
applied similar genomics tools to two amenable topics in nucleic acid 
modifications. First, I used mRNA-Seq to attempt to determine the substrate of 
the orphan cytidine deaminase Apolipoprotein B mRNA-editing enzyme, 
catalytic polypeptide 2 (APOBEC2). Next, I used whole-genome bisulfite 
sequencing to explore the distribution of 5-methylcytosine in Trypanosoma brucei. 
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Chapter 1. Introduction* 
The different behavior of the cells of an organism despite their shared 
DNA sequence has been one of the great motivating questions of molecular 
biology. One of the key advances in understanding this process has been 
recognition of the influence of chemical modifications of nucleic acids 
themselves. Although it has long been known that such an absolutist view of the 
central dogma is a gross oversimplification (Crick, 1970), the characterization of 
nucleic acid modifications has made it clear that DNA and RNA are not passive 
one-dimensional encodings of protein sequences. Rather, their properties can be 
altered by a wide array of modifying enzymes. The resulting menagerie of 
modified bases have crucial consequences for nearly every aspect of cell function 
(Grosjean, 2009). 
 
1.1 Nucleic acid modifications 
 Both DNA and RNA are biochemically modified in a staggering number 
of ways in the cell. RNA in particular displays great diversity in its 
modifications, with 144 identified to date (Limbach et al., 1994; Machnicka et al., 
2012). It is likely that RNA’s greater diversity is a consequence of both the larger 
number of roles that RNA plays in the cell and the importance of preventing 
deleterious changes in DNA. 
 These modifications are important for the function of nearly every type of 
RNA. Modifications of tRNA are both the most diverse and most frequent, with 
about 17% of bases modified in eukaryotic cells (Jackman and Alfonzo, 2012). 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
*	  Portions	  of	  this	  chapter	  were	  published	  in	  (Fritz and Papavasiliou, 2010)	  and	  
(Fritz et al., 2013)	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Perhaps most famously, the modified base inosine at position 34 of tRNAs is 
responsible for the “wobble” base pairing with the third position of the codon 
(Murphy and Ramakrishnan, 2004). In rRNA, modifications occur at a large 
number of functionally important regions and influence stability (Decatur and 
Fournier, 2002). Modifications, in particular pseudouridylation and 2’-O-
methylation, play a similar stabilizing role in snRNAs (Karijolich and Yu, 2010). 
Modifications of mRNAs include N6-methylation of adenosine, which is 
dynamically regulated and important for modulating RNA stability (Wang et al., 
2014). Also found within mRNA are the deamination modifications, which 
convert adenosine and cytosine to inosine and uracil respectively. This process, 
which also occurs in tRNA and miRNA, is termed RNA editing, and will be 
treated at greater length.  
DNA modifications, while smaller in number, still impact cellular function 
in a variety of important ways. These modifications can be assigned to two 
classes: those that are introduced enzymatically, and those that are not. The 
second class, which includes bases such as 8-oxoguanine, occur as a result of 
oxidative damage and do not appear to be functional (Cooke et al., 2003).  
With the exceptions of deamination of adenosine, cytosine, and its 
derivatives, all known enzymatic modifications of DNA bases do not affect base 
pairing. One well studied example is N6-methyladenosine, which among other 
functions is crucial in E. coli for discriminating between the template and newly 
synthesized strands for purposes of DNA repair (Barras and Marinus, 1989) and 
preventing re-replication of newly synthesized DNA (Russell and Zinder, 1987). 
Another notable DNA base is β-d-glucopyranosyloxymethyluracil, or base J, 
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which prevents transcriptional readthrough in Leishmania (van Luenen et al., 
2012). However the most prominent class of modified DNA bases in vertebrates 
are 5-substituted cytosines. These bases, 5-methylcytosine (5mC), 5-
hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine 
(5caC), appear to be the only persistent modified bases with functional 
consequences found in mammalian DNA (Figure 1.1). Of these, 5mC was the first 
discovered (Hotchkiss, 1948) and is by far the most abundant, most versatile, and 
best studied.  
 
1.1.1 DNA cytosine methylation 
1.1.1.1 Functions of DNA methylation 
 5mC in DNA is common to all domains of life and serves a wide variety of 
functions in different organisms. In E. coli, it is important for the regulation of 
stationary phase transcription (Kahramanoglou et al., 2012). In the fungus 
Neurospora crassa, cytosine methylation is crucial for silencing repetitive elements 
(Selker et al., 2003). The cytosine methylation system is extremely complex in 
Arabidopsis, where it maintains a silenced state for transposons and regulates 
gene expression (Stroud et al., 2013). In the ciliated protist Oxytricha trifallax, 5mC 
marks DNA for degradation during a complicated set of genome rearrangements 
that accompany reproduction (Bracht et al., 2012). Methylation of cytosine also 
appears to be important for life cycle stage-specific gene expression in the 
parasitic nematode Trichinella spiralis (Gao et al., 2012) and caste-specific gene 
expression in the honeybee (Elango et al., 2009). In many other organisms, such 
as the kinetoplastid T. brucei, the existence of DNA methylation has been 
reported, but its function is unknown (Militello et al., 2008). 
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A.        B. 
          
C.         D. 
       
 
Figure 1.1. 5-substitued deoxycytidine derivatives. (A) 5-methylcytosine, (B) 5-
hydroxymethylcytosine, (C) 5-formylcytosine, (D) 5-carboxycytosine. 
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In mammals, 5mC occurs predominantly in the sequence context CpG, 
which allows for symmetrical marking of both strands. Approximately 70-80% of 
cytosines in this context are methylated in mammalian DNA, which represents 
about 1% of the genome overall (Ehrlich et al., 1982). However there is also 
appreciable 5mC in non-CpG sequence contexts in certain mammalian cell types 
(Ramsahoye et al., 2000), and widespread methylation in other contexts in fungi 
(Rountree and Selker, 1997) and plants (Cokus et al., 2008). Notably, the 
dinucleotide CG is both globally depleted and unevenly distributed within 
mammalian genomes (Illingworth and Bird, 2009). This has been attributed to the 
higher inherent mutagenicity of 5mC compared to unmodified cytosine (Bird, 
1980) as well as the functional importance of the CpG-rich regions, which are 
termed “CpG islands.”  
 Originally, cytosine methylation in mammals was thought to function as a 
silencing mark that could explain stably inherited differences in gene expression 
between cellular lineages of an organism (Holliday and Pugh, 1975; Riggs, 1975). 
Many examples have since been found that clearly support the hypothesis that 
methylation of an element leads to its silencing. The inactive X chromosome is 
almost entirely methylated at CpG, and can be reactivated by loss of methylation 
(Mohandas et al., 1981). Retrotransposons are frequently densely methylated, 
and this methylation inhibits their mobilization (Yoder et al., 1997). Imprinted 
genes are also regulated by methylation, often with the silent allele modified (Li 
et al., 1993). Finally, many developmentally regulated genes are inhibited in a 
relatively straightforward manner by methylation, the prototypical case being 
Oct4 during transition from the ES cell state (Hattori et al., 2004). 
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However, it has become clear that DNA methylation is not a simple and 
absolute bar to transcription. The model that has emerged holds that at some, but 
not all, CpG island-containing promoters, methylation leads to long-term 
silencing, while at CpG-poor promoters, methylation has little effect on 
transcription (Jones, 2012). Silencing of promoters by CpG island methylation 
also seems to function primarily in early development, and is a minor means of 
gene expression regulation in later differentiation, if it occurs at all (Bock et al., 
2012). Additionally, it has been shown that DNA methylation is a part of a larger 
network of factors that are involved in silencing. It appears that silencing of a 
gene by other DNA-binding proteins generally precedes DNA methylation, 
which functions more as a heritable stabilizer of the silenced state (Cedar and 
Bergman, 2009).  
DNA methylation also has several functions that do not fit neatly into the 
classical promoter-silencing model. It appears that most of the functional 
differences in DNA methylation between differentiated cells occur at enhancers 
and insulators rather than promoters (Ziller et al., 2013). Gene bodies also vary 
widely in their levels of methylation, but the significance of this is still unclear 
(Jones, 2012). It has also been proposed that the lower levels of methylation in 
introns compared to exons may serve a functional role in splicing (Laurent et al., 
2010). 
 
1.1.1.2 Establishment and maintenance of DNA methylation 
 Shortly after implantation, the embryo undergoes a period of rapid 
methylation that is catalyzed by the “de novo” DNA cytosine methyltransferases 
DNMT3A and DNMT3B (Okano et al., 1999). This leads to a pattern of near-
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global methylation of CpG-poor sequences, with some CpG-rich regions 
protected by DNA binding protein such as SP1 (Macleod et al., 1994). After this 
initial pattern is established, it is maintained heritably by the action of the 
“maintenance” DNA cytosine methyltransferase DNMT1 (Li et al., 1992). This 
enzyme is able to faithfully reproduce DNA methylation patterns on newly 
synthesized DNA by means of its high specificity for the hemimethylated CpG 
duplex (Song et al., 2012). 
Specific loci become methylated later in development after binding by one 
of a number of silencing factors, such as the H3 lysine methyltransferases G9A 
(Feldman et al., 2006) or EZH2 (Viré et al., 2006). These factors recruit DNMT3 
enzymes, in addition to other silencing factors such as histone deacetylases. In 
turn, densely methylated sequences can recruit other silencing factors, such as 
MECP2, which can regenerate the repressive chromatin state following DNA 
replication (Nan et al., 1998). In this way, DNA methylation is better understood 
as a resilient scaffold upon which silencing occurs, rather than the effector of 
silencing itself.  
 
1.1.1.3 DNA demethylation 
While the means for the establishment and maintenance of DNA 
methylation in mammals is relatively well understood, the means by which the 
mark is removed from DNA is a far more controversial area. DNA 
demethylation occurs at several points during development. The most dramatic 
loss of methylation occurs immediately after zygote formation, when the 
paternally-derived genome undergoes almost complete demethylation in 6-8 
hours (Mayer et al., 2000). The maternally-derived genome undergoes 
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demethylation of similar scale but with much slower kinetics, achieving full 
demethylation at the morula stage (Howlett and Reik, 1991). The other large-
scale demethylation event that takes place is the “resetting” of the global somatic 
cell methylation in primordial germ cells (PGCs), the precursors to germ cells. 
Between E7.5 and E11.5, this population of cells lose most DNA methylation 
(Hajkova et al., 2002). Small scale, targeted demethylation events also take place 
during differentiation of somatic cells, which appear to be driven by proximal 
transcription factor binding (Stadler et al., 2011). 
Two broad classes of mechanisms have been proposed for DNA 
demethylation: passive and active. Passive demethylation refers to the dilution of 
DNA methylation through replication in the absence of maintenance methylation 
activity. This appears to be the dominant mechanism for demethylation of 
maternal genome in the zygote: methylation gradually decreases at the same 
time that oocyte-derived DNMT1 is excluded from the nucleus (Howell et al., 
2001). It may also account for some site-specific demethylation later in 
development, with various DNA-binding proteins occluding newly synthesized 
DNA and preventing access for DNMT1 (Hsieh, 2000).  
While the literature dealing with passive DNA demethylation is relatively 
straightforward, the mechanisms of active demethylation in mammals have been 
considerably more controversial. While direct, one-step reversal of cytosine 
methylation is too energetically unfavorable a process to occur, the AlkB family 
of enzymes have been shown to demethylate 1-methyladenosine and 3-
methylcytosine via oxidized intermediates, releasing the methyl carbon as 
formaldehyde and regenerating the original base (Falnes et al., 2002; Trewick et 
al., 2002). However, no comparable Alkb-family enzyme that accepts 5mC as a 
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substrate has been found in vertebrates. The methyl-CpG-binding protein MBD2 
has been proposed as such a direct DNA demethylase (Bhattacharya et al., 1999), 
but these findings could not be replicated (Bird, 2002). A problem with the direct-
demethylation candidates is that a number of studies indicate that DNA is 
broken and repaired in the course of demethylation (Barreto et al., 2007; Hajkova 
et al., 2010; Kress et al., 2006). A hypothesis not contradicted by these reports is 
that DNA demethylation in mammals is achieved by targeted removal of 5mC by 
a glycosylase without previous modification of the base (Jost, 1993). This is 
thought to be the dominant mechanism of active DNA demethylation in plants, 
with the DME/ROS1 family of glycosylases serving this function in Arabidopsis 
(Zhu, 2009). MBD4 has been proposed as this glycosylase in mammals (Kim et 
al., 2009b), although previous in vitro work found this enzyme to be far more 
active on thymidine than 5mC (Zhu et al., 2000). Other reports suggested that 
demethylation may proceed by a radical mechanism catalyzed by the elongator 
complex member ELP3 (Okada et al., 2010) or by conversion to thymidine by 
DNMT3-family enzymes under conditions of low S-adenosylmethionine 
(Kangaspeska et al., 2008; Métivier et al., 2008).  
Among all of these proposed mechanisms, the evidence most strongly 
supports two: demethylation by oxidation, and demethylation by deamination. 
The characterization of the TET family of enzymes has given credence to the 
former. These Fe(II)- and α-ketoglutarate-dependent enzymes convert 5mC to 
5hmC in vitro, and lead to global depletion of 5mC when overexpressed 
(Tahiliani et al., 2009). Subsequent work has shown that demethylation of the 
paternal zygotic genome (Gu et al., 2011b) and PGCs (Hackett et al., 2013) require 
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TET-family proteins, as do other examples of site-specific demethylation (Klug et 
al., 2013).  
There have also been a number of proposals as to the post-oxidation steps 
in TET-mediated demethylation. It has been suggested that C is directly 
regenerated by decarboxylation of 5caC (Schiesser et al., 2012), but no 
decarboxylase with such an activity has been identified. It is also possible in 
some cases that a pseudo-passive mechanism may take place, with 
hemihydroxymethylated CpG failing to serve as a suitable substrate for DNMT1 
(Inoue and Zhang, 2011), but the kinetics of some examples of active 
demethylation preclude this from serving as the only mechanism. A 5hmC-
specific (or 5fC- or 5caC-specific) glycosylase could also lead to net 
demethylation by base excision repair, and it has been suggested that TDG could 
serve this purpose (Maiti and Drohat, 2011). Beyond the possibility that TET-
mediated oxidation represents the mechanism of active DNA demethylation, the 
discovery of high levels of 5hmC in Purkinje neurons (Kriaucionis and Heintz, 
2009) and ES cells (Pastor et al., 2011) as well as the existence of proteins that 
have very high affinity for 5hmC (Mellén et al., 2012) and 5fC (Iurlaro et al., 2013) 
suggests that oxidized cytosine derivatives may be functional marks in their own 
right and not simply intermediates.  
The other well-supported mechanism for active demethylation in 
mammals involves deamination by cytidine deaminases. The observation that 
activation-induced cytidine deaminase (AID) and apolipoprotein B editing 
enzyme, catalytic polypeptide 1 (APOBEC1) can act on 5mC in DNA led to the 
hypothesis that the resulting T:G mismatch could be repaired in an error-free 
manor to yield net demethylation (Morgan et al., 2004). It has also been 
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hypothesized that deaminase-mediated damage could lead to processive-like 
demethylation by long-patch base excision repair, and could do so by acting on 
unmodified cytosine (Fritz and Papavasiliou, 2010). The evidence for and against 
deamination-mediated mechanisms of demethylation will be discussed at length 
in a later section. 
 
1.1.2 RNA editing 
The term RNA editing is used to describe two separate varieties of RNA 
modification: base-insertion/deletion editing, and base-modification editing. 
Insertion/deletion editing was the first type discovered, and involves the post-
transcriptional addition or deletion of internal uridines to yield RNA sequences 
that differ from their source DNA (Benne et al., 1986). This process is crucial for 
proper expression of certain mitochondrial genes in kinetoplastids, and is crucial 
for their survival (Schnaufer et al., 2001). 
While insertion/deletion editing is unique to kinetoplastids, base-
modification editing is much more widespread. The two types of base-
modification editing that occur in vertebrates are termed A-to-I editing, which is 
catalyzed by the ADAR family of proteins, and C-to-U editing, which is 
catalyzed by the AID/APOBEC family. A-to-I editing occurs extremely widely in 
mammalian transcriptomes, with more than 108 sites identified as being edited 
by ADAR at some level (Bazak et al., 2014). The majority of these events occur in 
Alu repeats in transcript 3’UTRs (Ramaswami et al., 2012). 
Adar-catalyzed editing has been shown to have a number of functional 
roles. Because ADAR enzymes show a preference for double-stranded RNA 
(Nishikura et al., 1991) and A-to-I editing disrupts complementarity, it has been 
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suggested that the general function of this type of editing is modulating RNA 
secondary structure. In support of this hypothesis, ADAR and the RNAi 
pathway appear to compete for substrates (Wu et al., 2011), and lack of ADAR1 
can lead to an inflammatory response consistent with overproduction of 
endogenous dsRNA (Hartner et al., 2009; Rice et al., 2012).  
Because inosine has similar base-pairing properties as guanosine, A-to-I 
editing can have direct effects on coding sequences as well. This mode of 
regulation diversifies the coding sequences of a number of ion channels (Burns et 
al., 1997; Higuchi et al., 1993; Hoopengardner et al., 2003), and has been shown to 
be a mechanism of temperature adaptation in octopi (Garrett and Rosenthal, 
2012). Such coding changes may also contribute to the anti-viral activity of 
ADAR (Hamilton et al., 2010).  
 
1.2 The AID/APOBEC family of cytosine deaminases 
The AID/APOBEC family of polynucleotide cytidine deaminases catalyze 
deamination of cytosine to yield uracil in single-stranded DNA, with some 
exceptions. They all possess at least one characteristic catalytic domain in which 
the histidine and cysteines of the motif H[AV]E-X[24-36]-PCX[2-4]C coordinate a zinc 
ion, which in turn activates a water molecule to add at the 4 position of cytosine 
(Conticello, 2008). Subsequent loss of ammonia yields net conversion of cytosine 
to uracil (Figure 1.2). While these proteins share a common mechanism, there is 
great diversity in the specific substrates and functional importance of the 









APOBEC1 was the first member of the AID/APOBEC family to be 
discovered (Teng et al., 1993). Its well-characterized activity is the site-specific 
editing of the ApoB transcript in small intestinal enterocytes. This editing results 
in a premature stop codon and translation of a truncated form of the protein with  
different properties in lipid metabolism (Chen et al., 1987; Powell et al., 1987).  
APOBEC1 is unique among the AID/APOBEC family as the only member 
for which RNA editing has been demonstrated in vivo. It has also been shown 
that APOBEC1 can edit a large number of transcript 3’UTRs in vivo (Rosenberg et 
al., 2011), and that is overexpression in the liver causes tumor formation 
(Yamanaka et al., 1997). In DNA, APOBEC1 can act on cytosine in E. coli (Harris 
et al., 2002) and cytosine and 5-methylcytosine in DNA in vitro (Morgan et al., 
2004). The latter observation led to the hypothesis that it may be involved in 
DNA demethylation, and there is some evidence that this may take place in 
neurons (Guo et al., 2011).  
 
1.2.2 APOBEC2 
APOBEC2 is clearly a member AID/APOBEC family by sequence 
similarity, and is evolutionarily well-conserved as far back as bony fish 
(Conticello, 2004). It has also been successfully crystalized, and displays folds 
characteristic of free nucleotide cytidine deaminases (Prochnow et al., 2006). 
Despite these features, no catalytic activity for this protein has been identified 
(Anant et al., 2001; Harris et al., 2002; Mikl et al., 2005; Nabel et al., 2012). 
However, a number of phenotypes have been reported in the absence of 
APOBEC2. It is expressed at high levels in skeletal and cardiac muscle (Liao et 
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al., 1999), with higher levels in slow-twitch fibers than in fast-twitch (Mikl et al., 
2005). Mice deficient in APOBEC2 display a higher proportion of slow-twitch 
muscle fibers, as well as decreased body mass and myopathy in later life (Sato et 
al., 2010). Mice that constitutively overexpress APOBEC2 may also develop lung 
and liver tumors at an elevated rate (Okuyama et al., 2012). In other species, 
more dramatic phenotypes have been observed. Knockdown of apobec2 in early 
development results in impaired left/right axis definition in Xenopus laevis, 
which was attributed to inhibition of TGF-β signaling (Vonica et al., 2011). In 
zebrafish, morpholino knockdown of apobec2 at the single-cell stage led to severe 
muscle dystrophy (Etard et al., 2010) or neuron loss, which was attributed to 
hypermethylation of the neurod2 promoter (Rai et al., 2008). Knockdown in adult 
zebrafish was also found to impair nerve regeneration following injury (Powell 
et al., 2012). 
 There is no consensus on how APOBEC2 achieves these effects. It has been 
hypothesized that APOBEC2 may be involved in DNA demethylation (Powell et 
al., 2012; Rai et al., 2008), RNA editing (Liao et al., 1999), or that it has lost its 
cytidine deaminase activity altogether and may act by a different mechanism 
(Etard et al., 2010; Sato et al., 2010; Vonica et al., 2011). 
 
1.2.3 The APOBEC3 subfamily 
Since its appearance in the placental lineage of mammals, the APOBEC3 
subfamily of proteins have undergone a number of fusions and expansions, 
resulting in a single Apobec3 gene in mice and 7 in humans (Conticello, 2008). The 
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rapid diversification of this subfamily in the primate lineage is not surprising 
given these enzymes’ function: restriction of viruses and retrotransposons.  
 APOBEC3G has been the most intensely studied of the APOBEC3s 
because of its identification as the HIV restriction factor antagonized by the viral 
gene product Vif (Sheehy et al., 2002). This activity is achieved by hypermutation 
of retroviral (-)-strand cDNA (Harris et al., 2003; Lecossier et al., 2003; Mangeat et 
al., 2003; Zhang et al., 2003). Other APOBEC3 enzymes display similar antiviral 
activity against other viruses (Chen et al., 2006; Delebecque et al., 2006; Russell et 
al., 2005; Turelli et al., 2004), and restrict retrotransposons (Esnault et al., 2005; 
Muckenfuss et al., 2006), and foreign DNA (Stenglein et al., 2010).  
 The potent antiviral activities of APOBEC3s come at the cost of oncogenic 
mutations. APOBEC3s generally (Alexandrov et al., 2013; Nik-Zainal et al., 2012; 
Roberts et al., 2013) and APOBEC3B specifically (Burns et al., 2013a; 2013b) have 
been linked to a variety of human cancers by their characteristic mutational 
spectra. 
 
1.2.4 Activation-induced cytidine deaminase (AID) 
Activation-induced cytidine deaminase (AID) was initially identified in 
1999 as a factor required for class-switch recombination (CSR) and 
immunoglobulin somatic hypermutation (SHM) (Muramatsu et al., 2000; 1999; 
Revy et al., 2000). The 24kD protein, encoded by the Aicda gene, is conserved 
among jawed vertebrates and appears to be the basal member of the APOBEC 
family (Conticello, 2004). Although it was initially hypothesized to be an RNA 
editor due to its similarity to APOBEC1 (Muramatsu et al., 1999), it has since 
been established that AID is able to convert cytosine to uracil in single-stranded 
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DNA, as demonstrated in E. coli (Petersen-Mahrt et al., 2002) and in vitro 
(Bransteitter et al., 2003; Chaudhuri et al., 2003; Dickerson et al., 2003).  
 
1.2.4.1 Class-switch recombination and immunoglobulin somatic 
hypermutation 
In the decade since AID’s discovery, a broadly accepted model for its roles 
in antibody diversification has emerged (Delker et al., 2009; Di Noia and 
Neuberger, 2007). In this model, AID initiates CSR and SHM by conversion of 
cytosine to uracil in different regions of the immunoglobulin (Ig) loci. CSR occurs 
as a result of the double-stranded breaks frequently produced in the course of 
repair of such lesions in the S regions of the IgH locus. Joining of breaks in 
different S regions results in a different constant region immediately 
downstream of the transcribed V(D)J and consequently to antibodies of a 
different isotype (Xu et al., 2012). SHM is initiated by AID deamination within 
the V(D)J region of Ig loci. Repair of these lesions proceeds with an unusually 
high error rate, leading to mutations and thus altering the affinity of the encoded 
antibody (Di Noia and Neuberger, 2007). Selection of cells bearing these mutated 
immunoglobulins leads to affinity maturation. AID is the sole initiator of these 
processes: Aicda-/- mice exhibit a complete lack of secondary Ig isotypes and no 
mutations in Ig variable regions during an immune response (Muramatsu et al., 
2000). Mutations in the AICDA gene in humans result in a similar condition 





1.2.4.2 Off-target effects of AID in B cells 
 Although AID displays striking specificity in its action on the Ig loci, it can 
act at other points in the genome. A large number of loci are mutated at an 
elevated rate in the presence of AID, including Bcl6 and Fas (Muschen et al., 2000; 
Pasqualucci et al., 1998; Shen et al., 1998). In some cases, notably mutations at 
Myc, these AID-catalyzed “non-Ig somatic hypermutations” have been shown to 
contribute to B cell tumors in mice (Pasqualucci et al., 2001). AID appears to act 
at a much larger number of loci, and that fidelity of repair following damage 
varies greatly at different sites (Liu et al., 2008). In addition, AID can catalyze the 
formation of DNA breaks, which can lead to translocations. The most notable of 
these is the Myc/Igh translocation that is characteristic of Burkitt’s lymphoma 
(Pasqualucci et al., 2007; Robbiani et al., 2008), but it has become clear that AID-
dependent DNA breaks are distributed broadly throughout the genome (Chiarle 
et al., 2011; Klein et al., 2011).  
 
1.2.4.3 AID and DNA demethylation 
Despite the lack of an obvious non-immune phenotype in AID-deficient 
mice, there are signs that AID has additional functions outside of antibody 
diversification. Notably, it is expressed in many cell types other than B cells, 
namely oocytes, PGCs, ES cells (Morgan et al., 2004), breast tissue (Pauklin et al., 
2009), and prostate epithelial cells (Lin et al., 2009), although its presence in PGCs 
has recently been challenged (Hajkova et al., 2010). As AID is a DNA mutator, its 
expression outside of B cells would likely have been strongly selected against if it 
had no function in these tissues. Further suggestions of functions for AID beyond 
the immune system come from studies of lower vertebrates. As in mice, AID 
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expression is found during early development in D. rerio (Rai et al., 2008), 
Xenopus (Marr et al., 2007), and the newt P. waltl (Bascove and Frippiat, 2010). 
The broad conservation of AID expression in early development strongly 
suggests a function at that stage.  
The first direct evidence that AID might have functions beyond the 
standard model of antibody diversification came in 2004, when it was shown by 
Petersen-Mahrt and colleagues that AID, along with the related cytidine 
deaminase APOBEC1, can convert 5mC in single-stranded DNA to thymidine in 
vitro (Morgan et al., 2004). This observation led to the proposal that these 
enzymes could function in DNA demethylation. 
AID could initiate demethylation by a damage-and-repair mechanism 
similar to that used in SHM (Figure 1.3). The deamination of 5mC by AID yields 
thymidine. This T would then be removed by a T-G mismatch-specific 
glycosylase, of which two, TDG and MBD4, are known in mammals (Hardeland 
et al., 2003; Millar et al., 2002). The resulting abasic site would then be replaced 
by an unmethylated cytidine via base excision repair (BER) processes, yielding 
the net removal of methylation without alteration of sequence. BER could also 
proceed through either short or long patch repair, potentially yielding 
demethylation of multiple neighboring cytosines in the latter case. This could 
give rise to the appearance of processive demethylation, despite originating from 
a single deamination event.  
The AID model of demethylation received a measure of in vivo validation 
from work in D. rerio early embryos (Rai et al., 2008). Introduction of a 
methylated DNA fragment into single-cell embryos induced expression of AID 




Figure 1.3. Proposed mechanisms of AID-dependent DNA demethylation. 
Deamination of 5mC by AID yields thymine. Excision of thymine by either of the 
mammalian T-G-specific glycosylases (TDG or MBD4) and subsequent error-free 
replacement with cytosine would yield loss of methylation at that base on one 
strand. Deamination of cytosine followed by excision of uracil and error-free 





Additionally, overexpression of AID along with the T-G glycosylase MBD4 leads 
to efficient demethylation of a methylated DNA fragment, with observable 
conversion of 5mC to T. Morpholino knockdown of AID or of MBD4 in D. rerio 
single-cell stage embryos results in hypermethylation of the promoter of the 
neurogenesis-related transcription factor neurod2 at 80% epiboly. Furthermore, 
both AID and MBD4 were also detectable at the locus by chromatin 
immunoprecipitation (ChIP), suggesting that the promoter’s methylation state 
was dynamic through development and not just the result of transmission of 
altered methylation state at the single-cell stage. Consequently, AID morphants 
displayed severe defects in neurogenesis consistent with decreased neurod2 
expression. The tissue- and locus-specific phenotype suggests that active 
demethylation may serve as a mechanism for regulating specific lineage 
decisions, as opposed to only resetting methylation state grossly in the zygote 
and germline. 
Intriguingly, Rai and colleagues also found that the Gadd45 family of 
proteins, previously implicated in active demethylation in Xenopus (Barreto et al., 
2007), were involved in AID-dependent demethylation. Combined knockdown 
of four of the six Gadd45 family members found in zebrafish sharply reduced 
demethylation of a reporter and increased methylation of the genome as a whole. 
It was thus suggested that Gadd45 serves as a scaffold to couple AID and MBD4, 
supported by the facts that Gadd45α promotes their association with a 
methylated reporter plasmid and that the three proteins also co-
immunoprecipitate. The apparent physical interaction of AID and Mbd4 
afforded by Gadd45 provides a mechanism for the tight coupling of deamination 
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to repair that would be necessary for demethylation without attendant 
widespread mutation, as has been noted (Law and Jacobsen, 2010). 
Although there is no direct evidence for deaminase-dependent effects on 
cytosine methylation in mammalian somatic tissue, a recent study has implicated 
AID in establishment of the hypomethylated state of mouse primordial germ 
cells (PGCs) (Popp et al., 2010). In this study, genomic DNA from sperm, total 
fetus, placenta, and male and female E13.5 PGCs from wild-type and Aicda-/- mice 
was bisulfite-converted and sequenced using the Illumina ultra-high throughput 
platform, a method termed BS-Seq or MethylC-Seq (Cokus et al., 2008; Lister et 
al., 2008). The resulting data provides a genome-wide map of cytosine 
methylation at single-nucleotide resolution. While the lack of sequencing depth 
precluded quantitative measures of methylation for every genomic cytosine, the 
coverage was more than sufficient to detect significant increase in methylation in 
Aicda-/- PGCs. This difference was more pronounced for female than for male 
PGCs, and was roughly homogeneous throughout the genome. The broad nature 
of the methylation increase implies that AID functions without regard to specific 
loci, and thus is a plausible component of germline methylation erasure. This 
report marks the first description of a non-immune phenotype in Aicda-/- mice. 
Further evidence of AID’s capacity to demethylate DNA in mammalian 
cells came in a recent study of reprogramming during interspecies heterokaryon 
formation (Bhutani et al., 2010). This system uses polyethylene glycol fusion of 
mouse ES cells with human fibroblasts to induce reprogramming of the human 
nucleus to an ES-like state with high frequency. Because reprogramming is 
known to involve demethylation, heterokaryon formation allows for study of 
demethylation in mammalian cells, albeit in a non-physiological context. 
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Knockdown of AID was found to significantly inhibit reprogramming as 
measured by transcript levels of the pluripotency markers Oct4 and Nanog. 
Methylation of the promoters of these genes was also significantly increased as a 
result of reduced levels of AID. As heterokaryons are non-dividing, AID-
dependent demethylation in this system is necessarily active. Similar deficiencies 
for AID-deficient cells have been noted for reprogramming by Yamanaka factors 
as well (Kumar et al., 2013; Sabag et al., 2014). 
While the evidence that AID has a role in demethylation is suggestive, 
there are still caveats. It has been found for all tested members of the family that 
deaminase activity is higher on C than on 5mC (Nabel et al., 2012). Additionally, 
a recent report detected no AID expression in mouse PGCs at E11.5, although a 
small level of AID expression was observed at E12.5 (Hajkova et al., 2010). As the 
epigenetic reprogramming of PGCs begins at E11.5, AID cannot be the sole agent 
of demethylation. This idea is consistent with the occurrence of significant, albeit 
reduced, demethylation in the PGCs of Aicda-/- mice compared to somatic cells. 
Whether AID-independent demethylation in these cells is a result of 5mC 
deamination by another member of the AID/APOBEC family or due to any of 
the mechanisms mentioned above is an open question. It is also possible that the 
AID/APOBEC family of deaminases have differing target gene preferences for 
demethylation, and thus play complementary roles in the genome-wide removal 
of cytosine methylation.  
Another issue raised by these results is the functional importance of the 
observed PGC hypermethylation, as Aicda-/- mice are fully viable. Even if AID 
were the sole agent of active demethylation, it is not clear that loss of this 
mechanism would result in a drastic phenotype. This view is supported by 
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evidence from A. thaliana, in which loss of all three 5mC-removing glycosylases 
in vegetative tissue leads to viable plants displaying increased methylation only 
at certain loci, and no genome-wide increase (Penterman et al., 2007). As DNA 
methylation is essential for parental imprinting, Popp and coworkers suggested 
that the consequences of PGC AID deficiency may lie in retention of a parental-
like epigenetic state. Data supporting this view lies in a small but significant 
difference that exists between wild-type and Aicda-/- mice in the relationship 
between litter size and birth weight (Popp et al., 2010). In normal mice, pups that 
are part of large litters tend to have lower birth weights, while Popp and 
colleagues report that in Aicda-/- mice this compensation is absent. 
Hypermethylated elements responsible for this phenotype have not been 
identified.  
  
1.3 Statement of the problem 
Despite over a decade of intense study, a number of open issues remain 
surrounding AID. The divergent findings regarding AID’s role in DNA 
demethylation raises the question of the scope of its involvement. Additionally, 
while it is clear that AID-mediated damage occurs, the effects of this damage on 
the average B cell have not been characterized. Finally, the issue of whether AID 
is able to edit RNA in vivo has never been rigorously addressed in the literature. 
 In each of these cases, the advent of high-throughput sequencing provides 
methods for genome-wide characterization of AID’s effects. This thesis presents 
the application of a number of genome-scale, sequencing-based methods to 
characterize the consequences of AID deficiency and overexpression on the 
activated B cell: mRNA-Seq and miRNA-Seq allow for measurements of RNA 
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expression and editing, while reduced-representation bisulfite sequencing assays 
DNA methylation. These analyses confirmed AID’s known role in 
immunoglobulin isotype switching, while also demonstrating that it has little 
other effect on gene expression. Additionally, no evidence of AID-dependent 
mRNA or miRNA editing could be detected. Finally, RRBS data failed to support 
a role for AID in the regulation of DNA methylation. Thus, despite evidence of 
its additional activities in other systems, antibody diversification appears to be 
AID’s sole physiological function in activated B cells.  
Following the conclusion of my studies of AID’s effects in B cells, I 
applied similar genomics tools to two amenable topics in nucleic acid 
modifications. First, I used mRNA-Seq to attempt to determine the substrate of 
the orphan cytidine deaminase Apolipoprotein B mRNA-editing enzyme, 
catalytic polypeptide 2 (APOBEC2). Next, I used whole-genome bisulfite 
sequencing to explore the distribution of 5-methylcytosine in Trypanosoma brucei. 




Chapter 2. Systematic characterization of the effects of AID on the B cell 
transcriptome and DNA methylome† 
 
2.1 Assaying AID-dependent changes in the activated B cell  
While AID-dependent effects have been reported in a variety of systems, I 
chose to investigate activated murine B cells for a number of reasons. First, B 
cells are the physiological setting for the highest levels of AID. I hypothesized 
that AID-dependent effects would be more apparent as well as more likely to be 
physiologically meaningful in the cell type with the highest levels of AID. 
Additionally, there were a number of practical concerns that made ex vivo 
stimulated B cells an attractive system. They are simple to derive in large 
quantities, with a single spleen supplying enough material for several types of 
experiments. Moreover, primary cells from the mouse that are cultured ex vivo 
closely approximate the physiological conditions of CSR, while providing far 
more uniformity than possible for any true in vivo system. Finally two useful 
mouse strains have already been generated: Aicda-/- (Muramatsu et al., 2000) and 
AID–miR-155T, which has a transgene containing a C-terminal AID-GFP-fusion 
and a mutation in the miR-155 target site, leading to overexpression of AID-GFP 
(Teng et al., 2008). In combination with the wild-type, these strains allowed 
investigation of dose-response relationships for any observed effects.  
The investigation began with high throughput sequencing of poly-A+ 
RNA, or mRNA-Seq. This technique was an attractive starting point for a 
number of reasons. First, it is high-throughput, with a single experiment yielding 
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expression data for every gene in the genome. Additionally, mRNA-Seq can 
provide useful data beyond simple expression profiles, most saliently here 
evidence of RNA editing. Finally, because most possible effects of a nucleic acid 
editing protein like AID would be manifested either directly or indirectly on the 
transcriptome, it is likely that mRNA-Seq would allow for detection of any of 
AID-dependent DNA demethylation, RNA editing, or damage responses to off-
target AID activity. 
 
2.1.1 Validation of the activated B cell culture system  
To ensure that ex vivo stimulation was occurring as desired and that each 
of the genotypes behaved as expected, I sought to validate the cell isolation and 
culture conditions. The criteria for stimulation conditions were as follows: (1) 
that the cells isolated were in fact naïve B cells and (2) that AID was efficiently 
induced. Both of these criteria were assessed by flow cytometry following 
negative selection of CD43+ splenic cells and stimulation in culture for 3d with 
anti-CD40, LPS, and IL-4. This suite of factors, which induce switching to IgG1, 
IgG3, and IgE, were used because they are known to produce high levels of CSR. 
Following stimulation, cells displayed forward and side scatter consistent 
with blasting B cells. Additionally, over 98% of cells displayed the surface 
marker B220, indicating that the dissection and cell purification were performed 
correctly (data not shown). In order to determine whether AID was efficiently 
induced, the cells were also stained with anti-IgG1 antibodies. Because CSR is 
absolutely dependent on AID, surface expression of secondary Ig isotypes such 
as IgG1 functions as a proxy for AID expression. Flow cytometry demonstrated 
the expected pattern of IgG1+ cells by genotype, with background levels for  
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Aicda-/-, 14% for WT, and 31% for AID–miR-155T (Figure 2.1). Because AID level 
is known to be positively correlated with rates of CSR, this pattern also 
demonstrates that AID is in fact overexpressed in AID–miR-155T cells, and that 
the AID-GFP fusion is CSR-competent. 
Additionally, AID expression itself could be detected by flow cytometry in 
the case of the AID–miR-155T mouse due to its C-terminal GFP fusion. As 
expected, no GFP expression was detectable for the Aicda-/- or WT mice. In the 
case of the AID–miR-155T mouse, over 85% of cells were GFP+, demonstrating 
that the culture conditions robustly induce AID expression. Because there are no 
alterations in the transgene contained by AID–miR-155T cells that should affect 
transcription, this figure is also a fair estimate of the fraction of WT cells that 
express AID under these conditions. For all subsequent B cell experiments 
(except for the noted exceptions), all material was derived from the same single B 
cell culture per genotype assayed in Figure 2.1. 
  
2.1.2  Generation, mapping, and validation of mRNA-Seq data 
RNA extracted from Aicda-/-, WT, and AID–miR-155T activated B cells was 
used to prepare mRNA-Seq libraries using a standard protocol with the addition 
of two sets of “spike in” control transcripts after poly-A+ selection (Figure 2.2). 
The first was the commercially available ERCC panel of precisely quantified 
RNAs (Jiang et al., 2011a) which allow determination of the lower limit of 
detection for gene expression. The second was 5 sets of “pre-edited” RNAs 
derived from Trypanosoma brucei variant surface glycoprotein (VSG) genes with a 
single C-to-T change introduced at a frequency of 50%, which serve as a positive 




Figure 2.1. Quantification of IgG1+ and GFP+ populations of ex vivo stimulated 
naïve splenic B cells used for subsequent experiments as determined by flow 
cytometry. Plotted populations are 7AAD-, B220+. 
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Following purification of poly-A+ RNA and addition of exogenous spikes, 
the RNA-Seq library was prepared via modifications of a standard protocol 
(Rosenberg et al., 2011). Briefly, the RNA was chemically fragmented with Mg2+ 
and high heat, then reverse transcribed with random hexamer priming. The 
resulting cDNA was made double stranded with a cocktail of DNA polymerases, 
and following end repair and generation of A-overhangs, this cDNA was ligated 
to Illumina adaptors to facilitate sequencing. The adaptor-ligated product was 
size selected by gel electrophoresis, enriched by PCR, and size selected once 
more before 100-cycle, single-end sequencing on the Illumina HiSeq 2000. 
After verifying that the resulting sequencing reads passed basic quality 
control measures, they were aligned to the reference genome in a splice-junction-
conscious manner, and with the exogenous spike sequences added as extra 
“chromosomes.” The resulting mapped reads were then compared to the 
Ensembl reference gene annotation (with certain alterations, as noted later) using 
the program Cufflinks in order to generate relative gene and isoform expression 
values. The resulting expression values have units of fragments per kilobase of 
transcript per million reads mapped, or FPKM. Because it is normalized to both 
length of transcript and number of reads mapped, FPKM provides a count-like 
unit that allows for comparison between samples for a given transcript, as well 
as between transcripts for a given sample. 
To determine the limits of detection for this measurement of gene 
expression, the resulting values were first compared for the ERCC controls alone. 
The ERCC panel consists of 92 RNAs with no similarity to any sequences in the 
mouse genome, which allows for fully exogenous measurement of the limit of 
detection of abundance for transcripts (Jiang et al., 2011b). The resulting 
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estimates of abundance were well correlated for each pair of samples for 
transcripts with > 5 FPKM, and were within a 2-fold difference as low as 0.1 
FPKM (Figure 2.2). Since an FPKM of 5 corresponds to the 16th percentile of 
expressed genes for this data set, this analysis demonstrates that the data 
presented should be sensitive to relatively subtle changes in most expressed 
genes and large changes even in poorly expressed transcripts.  
 
2.1.3  AID-dependent differences in immunoglobulin isotype abundance  
After verifying that the exogenous controls behaved as expected with 
respect to transcript quantification, the next validation step was to detect the 
expected difference between the samples sequenced: transcription of productive 
secondary Ig isoforms.  
Conceptually, this was no different than detecting differences in isoform-
level expression differences in any other gene, as all of the JH-C spliced 
transcripts should be derived from productive transcripts. However, because the 
existing standard gene annotations do not include JH segments, a standard gene- 
or isoform-expression analysis would give no information about the levels of 
CSR in the source cell population. I first found the correct coordinates for each Ig 
segment by mapping the sequences for each as listed in IMGT (Lefranc et al., 
2009) to the genome. I then manually generated annotations for each of the 5 
theoretically possible “isoforms” for each isotype (each of the germline promoter 
and JH,1-4 spliced to C1, followed by the remaining C exons) and used this set to 
replace the existing Ensembl IgH locus annotation. Quantifying expression at the 
isoform level and then summing the FPKM values for each of the J-containing 
IgH isoforms for each isotype then allowed for relative measures of CSR. 
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Figure 2.2 Quantification of ERCC controls for RNA-Seq. Pairwise comparisons 
of ERCC RNA spike levels for (a) Aicda–/– and AID–miR-155T samples (r = 
Pearson correlation coefficient) 
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As expected, nearly all JH-C spliced transcripts for the Aicda–/– sample 
were IgM or IgD, while the wild-type and AID–miR-155T samples both 
displayed appreciable amounts of IgE, IgG1, IgG2a, and IgG3-derived transcripts 
(Figure 2.3 A). Furthermore, apparent CSR frequencies were higher for AID–
miR-155T than for wild-type for each secondary isotype, consistent with 
previous reports (Teng et al., 2008). This result demonstrates that the RNA-Seq 
data generated are of sufficient depth and quality to detect large differences in 
isoform abundance, and also indicates that the B cells used display the expected 
AID-dependent differences at the RNA level. 
One caveat of measuring CSR by RNA-Seq is that it provides only a 
relative measurement. To determine how CSR frequencies quantified by RNA-
Seq analysis compare to standard measurements, and thus to generate a fixed 
peg that would allow conversion to absolute values, the fraction of IgG1+ cells as 
determined by flow cytometry were compared to the abundance of JH-Cγ1 
transcripts as a fraction of all JH-C transcripts (Figure 2.3 B). A clear linear 
relationship was observed, albeit with slope not equal to 1, which likely 
represents differing per-cell levels and/or sequencing efficiencies of different 
isotype transcripts. Determining these correction factors for each isotype should 
allow RNA-Seq to be used as quantitative tool for assaying absolute frequencies 
of CSR.  
 
2.1.4  AID has little effect on non-immunoglobulin gene expression  
With the sensitivity of the mRNA-Seq system thoroughly validated, 






Figure 2.3. Quantification of immunoglobulin isotype abundance. (A) Relative Ig 
isotype abundance by AID level as calculated by RNA-Seq. (B) Comparison of 
CSR to IgG1 as calculated by RNA-Seq and flow cytometry for 3 analyzed B cell 
genotypes. (m = slope of line of best fit) 
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Overall, the gene expression profiles were similar for the three samples, 
with a Pearson correlation coefficient > 0.995 for each pairwise comparison 
(Figure 2.4). Within these expression profiles, AID itself was clearly expressed at 
the expected level for each dataset. But besides AID, the short list of genes that 
with adjusted p-value < 0.05, > 2 fold-change differences between conditions, 
and FPKM of at least 5 for at least 1 condition (Table 2.1) was composed of 
elements predominantly annotated as pseudogenes in other references, or 
elements with RNA-Seq coverage characteristic of mismapped reads derived 
from paralogous transcripts. In addition, few transcripts that displayed a > 2 fold 
difference did so for more than one of the binary comparisons, suggesting that 
these apparent differences were the result of noise rather than authentic AID-
dependent effects. These findings are concordant with those from a lower-depth 
RNA-Seq comparison of Aicda–/– and wild-type under slightly different 
conditions (36 nt paired-end sequencing, and IL-4 plus anti-CD-40 stimulation, 
data not shown).  
I also used the RNA-Seq data to estimate the abundance of different 
transcript isoforms. Expression analysis at the isoform level again shows a high 
degree of similarity between Aicda–/–, wild-type and AID–miR-155T samples, 
with the previously discussed exception of IgH transcripts (Figure 2.5). The 
lower degree of correlation for the isoform-level comparison as compared to the 
gene-level is expected, due to the uncertainty inherent in assigning ambiguous 
reads to one of several isoforms.  
Overall, the analysis failed to detect any clear difference in gene 




Figure 2.4 Gene expression comparison for Aicda-/- and AID–miR-155T B cells. (r 




Table 2.1. Genes with at least 2-fold difference in expression, FPKM of at least 5 
for one condition, and adjusted p-value < 0.05 for Aicda-/- (KO) and AID–miR-
155T (TG) samples, from RNA-Seq data as determined by Cuffdiff. 
 
gene KO_FPKM TG_FPKM log2(fold_change) q_value 
Aicda 1.14 120.99 6.73016 0.00E+00 
Rpl7a-ps5 1.25 46.18 5.2117 0.00E+00 
Mfap5 0.54 5.74 3.4151 4.20E-09 
Gm14431 0.74 6.30 3.09394 3.71E-02 
Gm4245 0.74 6.30 3.09394 3.71E-02 
Havcr1 4.64 15.08 1.7006 3.91E-08 
Sgip1 5.75 17.04 1.5663 6.11E-09 
Cd9 3.57 9.84 1.46525 2.23E-03 
Gm3839 12.60 33.83 1.42458 3.89E-06 
Gm10327 3.13 8.35 1.41717 5.53E-03 
Gm10293 9.64 22.76 1.24041 3.14E-04 
Gm10709 169.32 379.70 1.16513 8.12E-12 
Ccr4 7.46 16.09 1.10807 8.60E-05 
Gnb4 8.24 16.75 1.0237 3.17E-03 
Pld4 17.09 8.03 -1.09064 4.12E-04 
Fcrl5 7.90 3.63 -1.12079 1.85E-02 
Oas1g 12.54 5.68 -1.14153 2.38E-02 
Ifitm3 96.35 43.11 -1.16026 1.63E-05 
BC094916 10.29 4.60 -1.16053 1.45E-02 
Oas2 9.24 3.89 -1.24865 1.07E-02 
Gm5431 5.29 2.22 -1.25388 1.45E-02 
Pydc3 9.58 3.96 -1.27535 3.76E-04 
Sla 15.16 6.17 -1.29709 1.04E-04 
Ccl5 634.25 250.14 -1.34233 0.00E+00 
Ifit3 18.77 6.42 -1.54769 8.43E-08 
AI607873 5.81 1.84 -1.66161 3.34E-04 
Serpinb1a 6.14 1.94 -1.66476 5.73E-05 
Pydc4 31.13 9.80 -1.66687 4.28E-12 
Plac8 85.76 24.07 -1.83303 1.13E-10 
Hist1h2af 122.00 25.14 -2.27855 0.00E+00 
C530028O21Rik 8.56 0.10 -6.4739 1.88E-03 
Alox5ap 47.78 0.40 -6.91307 1.95E-10 
Gm9493 484.50 1.56 -8.28029 0.00E+00 





Figure 2.5 Isoform expression comparison for Aicda-/- and AID–miR-155T B cells. 
(r = Pearson correlation coefficient)  
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possibility of AID-dependent changes in gene expression in B cells, they 
demonstrate that if such changes exist outside the Igh locus, they are likely too 
small to be physiologically relevant. While these findings are derived from 
analysis of a single sample in each case, a lower-depth RNA-Seq comparison of 
Aicda–/– and wild-type under slightly different conditions (36 nt paired-end 
sequencing, and IL-4 plus anti-CD-40 stimulation) also found high concordance 
between samples by AID level.  
 
2.1.5 AID has no effect on VH segment usage in naïve B cells  
AID deficiency has been associated with autoimmune disease and a 
skewed usage pattern of VH segments in both humans (Meyers et al., 2011) and 
mice (Kuraoka et al., 2011). Because our data were derived from naïve B cells 
non-specifically stimulated to undergo CSR ex vivo, any differences in VH gene 
usage between samples ought to mirror the in vivo repertoire prior to affinity 
maturation. Thus the mRNA-Seq data set generated should allow for 
determination of whether this previously observed effect occurred prior to 
affinity maturation. 
FPKM values for the entire set of VH segments were derived by using a 
separate annotation consisting of only Ig V segments, defined in relation to the 
IMGT sequences as previously described for J segments. Because only one VH is 
transcribed in a mature B cell, the measurements correspond to relative segment 
usage between samples. This transcript abundance analysis revealed only minor 
differences in VH transcript abundance between Aicda–/–, wild-type and AID–
miR-155T samples. Importantly, none of these exhibited a clear relationship with 
AID expression (Figure 2.6), strongly suggesting that the pattern of VH usage was  
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Figure 2.6. Relative frequencies of VH segment usage by AID level, as calculated 
by mRNA-Seq. Values shown are the top 50 VH segments for the WT sample. 
  
























































unaffected by AID. This result is in contrast to the pattern of VH usage in newly 
emigrant B cells in AID-deficient humans (Meyers et al., 2011; Yamane et al., 
2010), suggesting that the influence of AID over VH usage occurs after 
establishment of the primary repertoire and probably reflects the dynamics 
between AID-mediated affinity maturation and B cell survival, rather than a role 
in early B cell development.  
 
2.2 Assaying AID-dependent mRNA editing  
While it has become clear that AID’s roles in initiating CSR and SHM 
proceed via a DNA-editing mechanism (Di Noia and Neuberger, 2007), the 
question of whether AID can edit RNA in a cellular context remains open. 
Indeed, a number of reports have hypothesized AID-dependent RNA editing 
activity in B cells (Kobayashi et al., 2009; Muramatsu et al., 2000; Nonaka et al., 
2009). The RNA-Seq reads described in the previous sections were precisely the 
dataset required for answering this question in a rigorous manner. 
 
2.2.1 Refinement and validation of a comparative mRNA-Seq RNA editing-
detection pipeline  
 While RNA-Seq is often treated as simply a method for gene expression 
profiling, the sequences it generates contain far more information than just RNA 
abundance. In particular, comparing mapped reads to reference to identify 
recurrent mismatches is an effective strategy for identifying RNA editing events, 
as has been demonstrated in a number of reports (Bazak et al., 2014; Eisenberg et 
al., 2010; Ramaswami et al., 2013). Previous work in the laboratory demonstrated 
the particular utility of paired wild-type and specific deaminase-deficient 
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comparative RNA-Seq for identifying RNA editing events (Rosenberg et al., 
2011). By using the sequences from near-congenic, deaminase-deficient samples 
as a final filter, false positives arising from mismapping and genomic differences 
can be minimized. 
The pipeline applied to the sequencing data is described in Figure 2.7. 
Briefly, single nucleotide variants (SNVs) were considered candidate editing sites 
if they conformed to the following criteria: (1) had greater than 30x read 
coverage, (2) at least 20% apparent C-to-T editing, (3) were a minimum distance 
from a non-C-to-T SNV (1 kb if using reference, 10 kb if not), (4) were not 
significantly strand-biased, as determined by Fisher’s exact test, (5) were not 
located in regions that were not isogenic between the mice used, as determined 
by the frequency of non-C-to-T SNVs, and (6) did not occur in the Aicda–/– 
sample. These cutoff values were determined to minimize the false positive rate 
for a comparison of RNA-Seq data from Apobec1-/- and wild-type macrophages. 
Two parallel analyses were performed for positions within reference exons (to 
achieve the lowest possible background) and for all positions (to include 
positions in transcripts not found in the reference annotation). 
 
2.2.2 Validation of the RNA editing detection pipeline 
In order to determine the limits of detection of this pipeline, three analyses 
were undertaken. First, the fraction of the transcriptome covered under the 
parameters described was quantified. Second, apparent editing was analyzed for 
the “pre-edited” RNA spikes. Finally, the pipeline was applied to analogous 
RNA-Seq data for the bona fide RNA editor APOBEC1 (C. Hamilton and F.N. 
Papavasiliou, unpublished data). 
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Figure 2.7. Schematic of RNA editing detection pipeline. 
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To estimate the fraction of the transcriptome covered at least 30x and thus 
visible to this pipeline, the amount of coverage by base was computed for ERCC 
spikes with various FPKM values (Figure 2.8). More than 90% of bases of the 
transcripts with FPKM ≥ 10 had at least 30x coverage, while those with FPKM = 8 
had about 60% of bases with sufficient depth to be interrogated for editing by 
this strategy. For the B cell RNA-Seq datasets, roughly the top 6600 transcripts 
have FPKM ≥ 10 and are thus well covered by the RNA editing analysis. Thus 
this combination of analysis strategy and dataset is appropriate for identifying 
editing events in moderately to highly expressed transcripts.  
Next, editing was determined for the “pre-edited” controls added during 
preparation of the library. These RNAs were derived from 5 Typanosoma brucei 
variant surface glycoprotein (VSG) genes, which had a single C-to-T mutation 
through site-directed mutagenesis. For each VSG the wild-type and “pre-edited” 
varieties were transcribed in vitro, purified, quantified, and then mixed in a 1:1 
ratio, resulting in a population of transcripts approximating a 50% editing ratio 
at a single site. These pairs were added at a range of concentrations to the B cell 
RNA following poly-A+ selection. 
Application of the described pipeline allowed detection of the editing 
event in the exogenous “pre-edited” VSG RNA with FPKM = 23, but not for the 
VSG with FPKM = 7. Therefore this more stringent measure of the limit of 
detection for editing yields a similar answer to depth of coverage alone. Both 
show that, for this pipeline and this depth of sequencing, medium- to highly-
expressed transcripts are thoroughly interrogated for editing. However, editing 
events in poorly expressed transcripts are below the limit of detection. 
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Figure 2.8. Cumulative per-base coverage depth for ERCC spike transcripts with 
various expression values (FPKM), illustrating the portion of the transcriptome 




As a final validation, the pipeline was applied to RNA-Seq data for wild-
type and Apobec1-/- macrophages that had been generated for other purposes (C. 
Hamilton, unpublished data). A large number (> 40) of APOBEC1-dependent 
RNA editing events were identified by this method (Figure 2.9). Importantly, the 
reciprocal comparison was also performed; that is, the number of apparent 
editing events that were present in the Apobec1-/- sample but not in the wild-type. 
This count provides a measurement of the background noise of the technique 
(due to mismapping or genomic sequence differences). It also allows for 
computation of an implied false positive rate (IFPR), as # of events in the 
deaminase-deficient sample / # of events in the wild-type. For APOBEC1-
dependent editing in macrophages, the IFPR was 7-8%. This demonstrates that 
the pipeline is highly specific for detecting true editing events in mRNA, at least 
if the events have APOBEC1-like properties. 
 
2.2.3 No AID-dependent RNA editing events can be detected in mRNA  
With the pipeline thoroughly validated, it was then applied to the B cell 
RNA-Seq data discussed in section 2.1. This analysis revealed less than 10 
candidate editing sites in the AID–miR-155T and wild-type samples that were 
absent in the Aicda–/– sample (Figure 2.9). Approximately equal numbers of 
candidate sites were found in the reciprocal comparison, resulting in IFPRs of > 
75% for each condition. In contrast to APOBEC1, this strongly suggests that AID 
does not edit a large number of RNAs. Because the data presented is derived 
from a single sample for each genotype, estimates of the variance in apparent 
candidate editing events was not possible. However, the small number of such  
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Figure 2.9. Candidate editing event counts derived from samples from AID 
overexpressing, wild-type, and Aicda-/-, B cells, and wild-type and Apobec1-/- 
macrophages, for analysis pipelines incorporating the Ensembl reference gene 
model and using no outside annotation. 
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events enabled manual inspection of these candidates to determine with greater 
certainty whether AID-dependent RNA editing was occurring in these samples. 
To determine if there was a highly specific AID-dependent RNA editing 
event that was present in the sequencing data, reads for the few candidate AID-
dependent editing events were visually inspected. In each case these events were 
adjudged to be false positives because of one of the following criteria: near-
threshold distance from non-C-to-T SNVs, C-to-T mismatches also occurring in 
the Aicda–/– sample, or complete absence of apparent editing in the AID–miR-
155T sample. Thus, the method fails to detect AID-dependent editing of 
moderately or highly expressed polyadenylated RNAs. While these results do 
not exclude the possibility of AID-dependent editing of low-expressed or non-
polyadenylated RNAs, it is highly unlikely that editing of a highly expressed 
protein-coding transcripts takes place in B cells. 
 
2.3 Assaying AID-dependent changes in DNA methylation  
Although the mRNA-Seq analyses suggest that AID does not have large 
effects in B cells beyond its known roles in SHM and CSR, they did not exclude 
the possibility of AID-dependent DNA methylation occurring in a way that does 
not dramatically alter gene expression. Because AID-dependent changes in DNA 
methylation has been an area of intense interest (Bhutani et al., 2013; 2010; 
Cortellino et al., 2011; Kumar et al., 2013; Popp et al., 2010; Rai et al., 2008; 2010; 
Sabag et al., 2014), I decided to compare the methylomes of Aicda–/–, wild-type 




2.3.1 Generation of genome-scale methylation data by the reduced-
representation bisulfite sequencing (RRBS) method  
A number of techniques exist for generating genome-scale DNA 
methylation data (Harris et al., 2010). The most comprehensive of these is whole-
genome bisulfite sequencing (WGBS), in which genomic DNA undergoes 
bisulfite conversion (converting all cytosines to thymines, but leaving 5-
methylcytosines unchanged). The converted DNA is then sequenced and 
mapped to a reference genome. This allows the fraction of cytosines methylated 
at a given site to be calculated as the ratio of reads containing C to total number 
of reads covering that site. The advantages of this technique are its single-base 
resolution, direct and quantitative readout of methylation, and near-complete 
genomic coverage. However this superior coverage comes at a significant cost: 
because high depth is required for methylation ratios to be quantitative, it 
requires very deep sequencing per sample. For example, in a recent report the 
equivalent of 5 Illumina Hi-Seq lanes was required to achieve just 13x average 
coverage for a human sample (Heyn et al., 2012). 
To retain the advantages of bisulfite sequencing without the issues that 
come along with obtaining its extensive coverage, I chose to use reduced-
representation bisulfite sequencing (RRBS) to generate genome-scale methylation 
data (Meissner et al., 2008). This technique differs from WGBS by including 
digestion with the restriction enzyme MspI (which has restriction site C^CGG, 
and is insensitive to methylation) and size selection prior to bisulfite conversion. 
This strategy eliminates the completely uninformative reads that are frequent in 
WGBS, because each read must begin with a CpG dinucleotide. Because CpGs 
are very non-uniformly distributed in mammalian genomes (Illingworth and 
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Bird, 2009), using MspI sites as the ends of each sequencing insert has the added 
advantage of focusing sequencing on the CpG-rich, genic portion of the genome, 
as well as yielding more insert-internal CpGs, and thus more informative 
sequencing. The drawback of this focused coverage is that large CpG-poor 
portions of the genome will be entirely excluded by this technique. 
 
2.3.2 Validation and coverage analysis of RRBS data  
Genomic DNA from the same three B cell samples described in section 
2.1.1 was used to prepare RRBS libraries by a standard protocol (Gu et al., 2011a). 
Two lanes of multiplexed 50-cycle sequencing yielded 47-54 million reads per 
sample. Following removal of 3’ adapter sequence, the reads were mapped using 
the program Bismark (Krueger and Andrews, 2011). This program accounts for 
the complications of the non-complementarity of the two strands of the genome 
following bisulfite conversion and the expected incomplete conversion due to the 
presence of 5mC by first temporarily converting all C’s to T’s in the read and 
mapping against a C-to-T converted version of the genome, then doing the same 
for the G-to-A conversion, and finally reporting the best single result for each 
read. This technique resulted in 68-70% mapping efficiency for trimmed reads.  
Because 5mC is extremely rare in non-CpG contexts in B cells (Ziller et al., 
2011), the apparent level of methylation at these sites can be used to approximate 
the background error of RRBS-derived methylation measurements, which are 
due to incomplete bisulfite conversion and mismapping. All 3 samples displayed 
apparent overall methylation levels of < 1.5% for non-CpG sites, demonstrating 
that non-conversion error is not a factor in interpretation of this dataset. 
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In order to determine the extent of genomic coverage in the dataset, the 
number of informative basecalls was quantified for a number of types of 
features. This analysis demonstrated the excellent coverage of CpG islands (85% 
with ≥ 100 individual CpG measurements) and promoters (64%) (Figure 2.10). 
This coverage was achieved despite low overall genomic coverage (2% of 1 kb 
windows with ≥ 100 individual CpG measurements), demonstrating the 
efficiency of targeting achieved by RRBS. To be included in subsequent analyses 
it was required that a CpG be covered at least 10x in all 3 samples, which yielded 
nearly 950,000 sites.  
 
2.3.3 RRBS fails to detect AID-dependent differences in DNA methylation  
To determine whether AID has a gross effect on the B cell DNA 
methylome, the distribution of methylation frequency for various genomic 
features was compared for the three AID genotypes. For each genomic feature  
type analyzed (1 kb windows, individual CpGs, CpG islands and promoters), 
there was no apparent difference in DNA methylation distributions associated 
with AID expression (Figure 2.11). The mean methylation frequency for each set 
of features was highly similar for each genotype. For each feature type, the 
expected bimodal distribution of methylation was observed, with proportionally 
more 1 kb windows near-fully methylated than the other feature types.  
To assess more subtle differences in DNA methylation by AID expression, 
methylation frequencies of individual features for each pair of samples were 
compared. For each feature set analyzed, methylation frequencies between 
samples were very strongly correlated (Figure 2.12). For 1 kb windows, a Pearson 




Figure 2.10. RRBS coverage of (a) 1kb genomic windows, (b) gene promoters, (c) 
CpG islands, and (d) CpG island shores for the WT sample. Promoters were 
defined as -5kb to +1kb from the TSS in Ensembl annotation, CpG islands were 
taken from the cpgIslandExt track of the UCSC table browser, and island shores 
were defined as 2kb up or downstream of a CpG island. 
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Figure 2.11. Distribution of DNA methylation frequencies in activated B cells by 
AID expression as determined by RRBS for (a) 1 kb windows, (b) individual 
CpGs, and (c) CpG islands. Width along x-axis denotes relative frequency of 
features with given level of methylation. Black horizontal line is sample median; 







Figure 2.12. Pairwise comparisons of methylation frequency in AID-
overexpressing and Aicda–/– B cells for (a) 1 kb windows and (b) all CpGs, as 
determined by RRBS. (r = Pearson’s correlation coefficient) 
 
	  55 
reported r for methylation values of 1 kb windows for biological replicates of 
cells in the hematopoietic lineage is 0.997 (Bock et al., 2012). This suggests that 
any overall changes in DNA methylation attributable to AID are much smaller in 
magnitude than can be detected by this technique. 
 
2.3.4 Attempted validation of AID-dependent differentially methylated 
regions  
The high degree of correlation of methylation values between samples did 
not exclude the possibility that sampling noise could mask small numbers of true 
AID-dependent changes in methylation. To determine if this was the case, I 
sought to independently verify the largest apparent AID-dependent decreases in 
DNA methylation identified by RRBS. To this end, the Sequenom Epityper 
system was used to assay the most promising candidate regions for AID-
dependent demethylation. This technique involves bisulfite conversion of DNA 
followed by PCR amplification, in vitro transcription, base-specific RNA  
cleavage, and mass spectrometry of the resulting product. The relative masses of 
the resulting spectral products can be used to determine absolute levels of 
methylation at each cytosine in the original genomic DNA. Because it is targeted 
to a known genomic region and samples large numbers of DNA molecules in one 
measurement, it reduces the error resulting from mapping and sampling noise 
that are inherent in RRBS. 
The regions selected for analysis were those that had > 20% higher 
methylation in the Aicda–/– sample than in the wild-type as measured by RRBS 
and that also were easily accessible in terms of primer design. Randomly selected 
regions with < 10% difference in methylation between samples were also assayed 
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to validate the technique. High quality data for all 3 genotypes was obtained for 
8 apparently AID-dependent hypermethylated CpGs and 18 similarly 
methylated CpGs that were also well covered by RRBS.  
For the candidate differentially methylated CpGs, the methylation 
frequencies for the Aicda–/– sample as determined by RRBS were generally much 
higher than as determined by Epityper (Figure 2.13 A). In contrast, these 
methods gave similar values for the wild-type and AID–miR-155T samples. The 
fact that the apparent AID-dependent hypermethylated CpGs are not 
reproducible and yield uniformly lower methylation values when assayed by an 
independent technique strongly suggests that the RRBS-derived values for these 
CpGs represent overestimates of the true population mean methylation 
frequency, due to noise or an artifact of the method. Additionally, the set of 
CpGs with similar methylation values between samples by RRBS displayed 
excellent agreement in methylation frequencies as determined by the two 
methods (Figure 2.13 B), demonstrating that RRBS as performed here yields 
accurate methylation values for well-covered CpGs. Taken together, these results 
suggest that the most extremely hypermethylated CpGs in the Aicda–/– sample 
were not a result of an authentic AID-dependent process.  
 
2.3.5 AID-dependent changes in DNA methylation and mRNA abundance do 
not suggest function  
Finally, in an attempt to locate any subtle but biologically meaningful 
AID-dependent changes in DNA methylation, the fold-changes in gene 







Figure 2.13 Comparison of DNA methylation frequencies as determined by RRBS 
and Epityper for a random subset of CpGs with (A) > 20% greater methylation in 
Aicda–/– than in WT and (b) CpGs with < 10% difference between Aicda–/– and 
WT. Lines are best linear fit for Aicda–/– or pooled WT and AID–miR-155T data. 
(m = slope of line of best fit) 
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for each pair of samples (Figure 2.14). Each pairwise comparison between 
genotypes showed that these variables were uncorrelated (|r| < 0.03 in all cases), 
suggesting that the observed modest differences in DNA methylation were not 
associated with changes in gene expression and therefore were unlikely to be 
physiologically relevant. As a whole, these results demonstrate that no candidate 
for consistent AID-dependent loss of methylation in B cells can be identified by 
RRBS. 
 
2.4 Assaying AID-dependent changes in miRNA abundance and sequence  
Although it appears that none of mRNA expression levels, RNA editing, 
or DNA methylation are affected by AID outside of the Ig loci, there of course 
remain other classes of nucleic acids that the previously described analyses do 
not address, such as miRNAs. Because AID has been implicated in the mutation 
of miRNA genes (Robbiani et al., 2009) as well as the editing of miRNAs 
themselves (Kobayashi et al., 2009; 2011), I sought to characterize the effects of 
AID deficiency on the miRNAome in terms of both abundance and sequence.  
 
2.4.1 Generation and mapping of miRNA-Seq data  
 In order to minimize the differences in genomic sequence between the 
samples used and maximize the AID levels in the B cell, a retroviral  
complementation strategy was used to generate material for miRNA-Seq. Aicda-/- 
B cells were stimulated in culture with LPS and IL-4 and infected with 
retroviruses to induce stable overexpression of either AID and GFP, or GFP 
alone. At 24h and 48h after infection, GFP+ cells were sorted by flow cytometry to 
yield pure populations of infected cells. These flow cytometric measurements  
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Figure 2.14 Comparison of differences in gene expression and methylation in the 




indicated that GFP was induced in both populations, and that switching to IgG1 
occurred only in the AID-overexpressing sample.  
After total RNA was extracted from the sorted B cells, miRNA-Seq 
libraries were prepared according to a standard protocol (Hafner et al., 2012). 
First, an RNA linker containing a sample-specific barcode was ligated to the 3’ 
end of all RNAs. This was followed by PAGE size selection to yield only miRNA-
sized products. Next, another RNA linker was ligated to the 5’ end, ensuring that 
only 5’-phosphorylated small RNAs would be sequenced. These species were 
then reverse transcribed, amplified by PCR, and sequenced on an Illumina HiSeq 
2000. The resulting sequencing data was first trimmed to remove adapter 
sequence and then mapped against the genome, allowing unique mappings only.  
 
2.4.2 AID has little effect on miRNA abundance  
Reads overlapping miRNA sequences as annotated in miRBase were 
counted and normalized to million reads mapped for each of the four samples. 
These counts were compared for each pair of samples. For both time points, 
miRNA abundance was well correlated between the samples, with Pearson 
correlation coefficients exceeding 0.95 in every case (Figure 2.15). While this does 
not exclude the possibility that AID may have some subtle effect on miRNA 
abundance, it suggests that any such effect is unlikely to be large enough to be 
physiologically significant.  
 
2.4.3 No AID-dependent RNA editing events can be detected in miRNA  
To determine whether AID acts as an editor of miRNAs, an RNA editing 




Figure 2.15. Abundance of small RNA-Seq reads overlapping annotated miRNAs 
that make up at least 0.1% of any sample for B cells overexpressing AID or GFP 
for 1 d or 2 d, normalized to million reads mapped. Points are colored according 
to time. 
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positions with at least 10% mismatches and at least 10x depth were identified 
and classified by type of base change. Because there is no known example of C-
to-T editing in miRNAs, the observed frequencies of each possible base change 
type were quantified to get an idea of whether AID-dependent miRNA editing 
could be widespread. However, C-to-T changes were among the least common 
base alterations observed (Figure 2.16 A). For each base change type, including 
C-to-T, the frequency observed was approximately the same for each sample. 
These likely represent sequencing error, mismapping, or other types of RNA 
editing that do not depend on AID. For instance, A-to-G alterations constitute the 
most common change observed for all samples, and are possibly the results of 
ADAR-catalyzed editing (Alon et al., 2012; Kawahara et al., 2007; Vesely et al., 
2012; Yang et al., 2005). 
To look more specifically at potential AID-dependent editing, unique 
mismatched sites were analyzed. These were defined as events that did not occur 
in the corresponding sample at the same time point while using a lower depth 
threshold. Again, C-to-T sites were among the least frequent (Figure 2.16 B). 
Only one C-to-T site for each of the AID-overexpressing samples fulfilled these 
criteria. These sites do not appear to be authentic RNA editing as they have 
insufficient depth in the GFP-only overexpressing sample to compare, and they 
occur at nearly 100%, suggesting a genomic SNV or mismapping. Thus, if AID-
catalyzed editing of miRNAs occurs, it does so at a rate that is well below the 










Figure 2.16. Number of (A) total and (B) unique observed mismatches for each 




Chapter 3. Progress towards identification of the substrate of APOBEC2 
3.1 Motivation  
Despite the existence of a crystal structure (Prochnow et al., 2006), 
knockout mouse (Mikl et al., 2005), and its long evolutionary conservation 
(Conticello, 2004), very little is known about the biological function of the 
putative cytosine deaminase APOBEC2. While the Apobec2-/- mouse displays shift 
in muscle fiber type balance (Sato et al., 2010) and knockdown in zebrafish leads 
to muscular dystrophy (Etard et al., 2010), precisely how this is accomplished is 
unclear. More fundamentally, no deaminase activity for APOBEC2 has been 
demonstrated on any substrate, DNA or RNA. Because this problem seemed 
amenable to the genomics techniques that I had become familiar with in the 
work described in chapter 2, I decided to undertake studies with the primary 
goal of identifying the substrate of APOBEC2.  
 
3.2 Analysis of APOBEC2 activity in primary myoblasts  
I chose to use primary myoblasts differentiated in culture as a system for 
investigating the role of APOBEC2 because they fulfilled a number of key 
criteria. First, these cells are a commonly used system for recapitulating muscle 
differentiation in culture. Additionally, it had previously been demonstrated that 
APOBEC2 is induced upon differentiation in a myoblastic cell line (Vonica et al., 
2011). Because the choice of fiber-type is thought to be set before fiber formation 
(Braun and Gautel, 2011), the differentiation process seems like the mostly likely 
setting for APOBEC2 to be exerting its physiological effects. 
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3.3 Establishment and validation of the primary myoblast culture system  
Myoblasts are naturally resident in the muscles of neonatal mice, and 
protocols for their culture are well established (Danoviz and Yablonka-Reuveni, 
2011). Following thorough dissection of the leg muscles, I isolated myoblasts by 
taking advantage of their resistance to adhesion. Rounds of pre-plating on 
standard tissue culture dishes cause the contaminating fibroblasts to adhere, 
while leaving myoblasts in the supernatant. Re-plating on collagen-coated dishes 
in the presence of basic fibroblast growth factor, hepatocyte growth factor, and 
high levels of FBS (20%) allows the myoblasts to adhere and divide for periods of 
weeks. Once myoblasts grow to roughly 70% confluence, they can be induced to 
differentiate by withdrawal of growth factors and changing from 20% FBS to 5% 
horse serum.  
To determine if the cultured cells were in fact myoblasts, 
immunofluorescence microscopy was performed to detect the muscle lineage 
marker MyoD and the myotube differentiation marker MyHC. The images from 
undifferentiated cells show that nearly all cells present express MyoD, and thus 
are not contaminating fibroblasts (Figure 3.1 A). At this time point, very few cells 
express MyHC, and no cell fusion is apparent. However at 24h after serum 
withdrawal, nearly all cells express MyHC, and many fusion events are observed 
(Figure 3.1 B). By 48h after serum withdrawal, fusion has progressed to the point 
that nearly all nuclei are part of a continuous unicellular network (Figure 3.1 C). 
Unfortunately, attempts to stain for APOBEC2 using a Western-competent 
antibody failed, with similar levels of signal observed in the Apobec2-/- sample.  
To verify that APOBEC2 induction in primary myoblast system had 
similar kinetics to that previously reported for a myoblastic cell line  
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Figure 3.1 Immunofluorescence microscopy images of myoblasts at 10x 
magnification (A) prior to differentiation, (B) 24h after differentiation and (C) 48h 







(Vonica et al., 2011), Apobec2 RNA levels were assayed over the course of 
differentiation. Two sets of wild-type myoblasts were lysed for RNA 
immediately before differentiation and for each of the next 5 days. Following 
conversion to cDNA, Apobec2 levels were measured by quantitative RT-PCR. 
This analysis revealed that Apobec2 transcript levels increase approximately 8-
fold 1 day after serum withdrawal, and remain at roughly that level throughout 
differentiation (Figure 3.2).  
To determine the kinetics of APOBEC2 protein expression in the system, 
protein lysates were harvested from both wild-type and Apobec2-/- cultures prior 
to differentiation and 1 and 2 days after. Western blotting revealed that, in 
contrast to RNA levels, protein levels of APOBEC2 are still rising at 1 day after 
differentiation, and reach high levels at 2 days after (Figure 3.3). For this reason, 
days 1 and 2 after differentiation were used as time points for subsequent 
studies. Additionally, no APOBEC2 protein could be detected in the Apobec2-/- 
samples, despite similar reductions in levels of MYOD1 and overall cell 
morphology.  
 
3.4 APOBEC2-dependent changes in gene expression  
 To identify APOBEC2-dependent changes in gene expression or RNA 
sequence that could lead to identification of a substrate, an mRNA-Seq dataset 
was generated from differentiating myoblasts. Myoblasts were prepared from a 
pair of Apobec2-/- and wild-type 10-day old littermates and grown to 70% 
confluency. RNA was harvested prior to differentiation and at 24 and 48 hours 
afterwards, and this RNA was used to prepare mRNA-Seq libraries by a protocol 
similar to that described in 2, but lacking exogenous spikes.  
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Figure 3.2. Apobec2 RNA levels after differentiation for primary myoblasts, as 
determined by quantitative RT-PCR. Values are relative to Gapdh and to 
Apobec2 levels for the undifferentiated sample. For each of the 5 timepoints, 
each measurement was taken in triplicate. Colors correspond to replicates. 
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Figure 3.3. Apobec2 and MyoD protein levels after differentiation for primary 




 For both the 24h and 48h pairs of samples, the correlation between the 
resulting gene expression values was very high (Figure 3.4). However in contrast 
to the results observed in the B cell mRNA-Seq, a number of genes were well-
covered and had significantly different expression levels between the samples 
(Table 3.1). Besides Apobec2 itself, this list of genes notably includes genes from 
two imprinted loci: the miRNA genes Rian and Meg3, which are derived from the 
Gtl2 locus, and Cdkn1c, which is derived from the Kcnq1 locus, were all 
upregulated approximately 2-fold in both wild-type samples. Given APOBEC2’s 
reported involvement in DNA demethylation (Rai et al., 2008; 2010) and the 
importance of DNA methylation in the regulation of imprinted genes 
(Bartolomei and Ferguson-Smith, 2011), these loci appeared to be prime 
candidates as targets of APOBEC2. 
 
3.5 APOBEC2-dependent changes in miRNA abundance  
 Because APOBEC2-dependent changes appear to be present in 2 miRNA 
primary transcripts in myoblasts, the RNA samples described in the previous 
section as well as another biological replicate similarly prepared were also used 
to prepare miRNA-Seq libraries. Quantification revealed approximately 2-fold 
increases in the wild-type samples for a large number of miRNAs derived from 
the Gtl2 locus, in concordance with the mRNA-Seq findings (Table 3.2). This 
further suggested that APOBEC2 may have a role in the regulation of the Gtl2 








Figure 3.4 Gene expression values for wild-type and Apobec2-/- samples at (A) 1d 
and (B) 2d after differentiation, from mRNA-Seq. Points in red are significantly 
different, as determined by Cufflinks. (r = Pearson correlation coefficient) 
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Table 3.1 Genes significantly different in myoblast for at least one comparison 
and with FPKM > 1 in at least 1 sample. (W_d1 = wild-type FPKM at 1 day post-
differentiation, K_d1 = Apobec2-/- FPKM at 1 day post-differentiation, W_d2 = 
wild-type FPKM at 2 days post-differentiation, K_d2 = Apobec2-/- FPKM at 1 day 
post-differentiation, d1_q = adjusted p-value for day 1 comparison, d2_q = 
adjusted p-value for day 2 comparison) 
 
gene W_d1 K_d1 d1_q W_d2 K_d2 d2_q 
Gm7325 379.45 353.53 1.00E+00 212.27 149.90 1.30E-03 
Cdkn1c 208.59 127.35 4.61E-05 84.76 59.23 5.86E-05 
Meg3 191.18 109.97 1.30E-01 47.65 20.62 9.75E-04 
Apobec2 107.58 0.06 0.00E+00 117.76 0.07 0.00E+00 
Rian 89.68 48.22 1.82E-06 28.62 12.84 4.61E-12 
Eif2s3y 34.44 54.52 1.00E+00 39.07 64.34 7.83E-03 
2410018M08Rik 1.05 38.13 3.25E-07 42.15 36.28 1.00E+00 
Ptprs 13.81 19.55 8.34E-01 22.18 31.76 2.67E-03 
2810453I06Rik 14.74 3.96 1.95E-06 20.39 21.32 1.00E+00 
Daam2 4.76 11.22 1.95E-09 7.26 13.76 3.07E-12 
Gm17517 11.38 0.93 0.00E+00 0.95 12.65 0.00E+00 
Rftn1 7.82 2.66 4.60E-05 12.34 6.07 5.85E-05 
Gm10269 2.85 9.39 2.13E-02 3.08 3.37 1.00E+00 
Polh 7.62 4.77 1.00E+00 8.88 4.88 3.78E-03 
Mafb 2.79 1.79 1.00E+00 7.83 4.69 5.35E-03 
Snapc1 7.29 4.31 1.00E+00 7.71 4.25 2.96E-02 
Gm17646 3.68 6.44 3.20E-03 6.52 4.02 5.46E-05 
Ifi202b 3.72 1.88 8.53E-01 6.42 3.17 3.05E-02 
Gm17492 3.36 6.18 1.99E-03 6.23 3.88 2.55E-04 
Rbpsuh-rs3 0.00 5.11 3.57E-09 3.07 0.00 1.64E-08 
Usp9x 3.64 0.00 5.95E-23 0.01 0.01 1.00E+00 
H2-Gs10 0.38 1.92 3.70E-05 0.49 0.45 1.00E+00 









Table 3.2 miRNAs with greater than 1.5-fold average increases for the wild-type 
as compared to Apobec2-/- in both 1d and 2d samples. miRNAs derived from the 
Gtl2 locus are highlighted in yellow. 
 
name chr start end avg_fc_d1 avg_fc_d2 
Mir669l 2 10390598 10390695 2.3274 2.6468 
Mir873 4 36615543 36615619 3.0290 3.0820 
Mir592 6 27886655 27886750 1.5432 3.5210 
Mir196a-1 11 96126478 96126579 1.9639 2.5010 
Mir338 11 119876079 119876176 2.5706 2.0878 
Mir673 12 110810200 110810290 1.5325 2.0765 
Mir493 12 110818443 110818525 1.5693 2.2964 
Mir433 12 110829925 110830048 1.5672 1.7134 
Mir379 12 110947235 110947357 2.2052 1.5072 
AC121784.4 12 110948819 110948935 2.1054 1.7742 
Mir666 12 110955295 110955393 1.5174 1.5725 
Mir543 12 110955466 110955545 1.8647 2.0442 
Mir495 12 110956957 110957036 1.7691 1.6591 
Mir381 12 110965032 110965106 1.9228 1.6067 
Mir487b 12 110965543 110965624 1.5535 2.1474 
Mir154 12 110976634 110976717 2.4047 1.5996 
Mir412 12 110981499 110981578 1.6868 1.8079 
Mir369 12 110981628 110981706 1.7411 1.8111 
Mir410 12 110981925 110982005 1.7402 1.5189 




3.6 Methylation analysis of candidate imprinted loci  
 The APOBEC2-dependent changes in transcript and miRNAs levels 
derived from the Kcnq1 and Gtl2 loci suggested that APOBEC2 might regulate 
these imprinted loci via DNA demethylation. To investigate this further, the 
methylation status of the imprinted control regions (ICRs) of these loci was 
assayed by targeted bisulfite sequencing using genomic DNA from the same 
myoblast samples. Following bisulfite conversion of the DNA from the 
undifferentiated and d1-differentiated samples, amplified products from the 
ICRs were subcloned into a sequencing vector and at least 10 clones were 
sequenced from each sample for each amplicon. 
 For the only amplicon tested for Kcnq1 and for 3 of the 5 amplicons tested 
for Gtl2, there were no differences between the samples. For the remaining 2 Gtl2 
amplicons, methylation was consistently 20-30% higher in the wild-type than in 
the Apobec2-/- sample (Figure 3.5). This was not the expected result, as 
methylation of this ICR has previously been shown to be inhibitory to expression 
of Meg3 and Rian (Ferguson-Smith, 2011). To determine whether this difference 
was due to APOBEC2, the undifferentiated samples of each genotype were also 
sequenced. This revealed that there was almost no change in methylation over 
the course of differentiation, and thus the observed differences were not 
APOBEC2-dependent. It is possible that the observed differences in methylation 
were due to heterogeneity in preparation of the myoblasts or strain differences in 







Figure 3.5 Methylation levels for 2 regions of the Gtl2 ICR, for wild-type and 
Apobec2-/- samples prior to differentiation and 1 day post-induction. Each column 



















































3.7 No APOBEC2-dependent editing is apparent in cultured myoblast 
mRNA  
To check whether APOBEC2-dependent RNA editing was occurring in the 
differentiating myoblasts, an RNA editing detection pipeline similar to that 
described in chapter 2 was applied to the mRNA-Seq data. Again, subject to 
cutoffs for minimum coverage depth and percentage apparent editing, C-to-T 
changes that were present in the wild-type but not the Apobec2-/- sample were 
identified. In this case another filter was added, in which reads overlapping 
candidate editing sites were realigned with the program BLAT (Kent, 2002) and 
then the fraction of mismatches at the site recounted. This strategy has been 
previously shown to reduce false positives that are the result of mismapping 
(Peng et al., 2012). While VSG spikes were not used in the preparation of this 
library, the numbers of aligned reads were similar to those in the B cell samples, 
so a similar portion of the transcriptome was likely covered.  
Application of the pipeline to the 1d-differentiated sequencing data 
resulted in a greater number of apparent candidate editing events (81) in the 
Apobec2-/- sample as in the wild-type sample (59), for an IFPR of > 100%. This 
strongly suggests that APOBEC2-dependent RNA editing, if it occurs, does not 
occur at a high frequency. To determine whether such editing occurs at all, the 
supporting RNA-Seq reads for each of the candidate editing events were visually 
inspected. All but two were rejected because of distance to a non-C-to-T SNV or 
distance from a splice junction. To determine whether these two candidate 
events were in fact true RNA editing, the sequences were amplified from the 
genomic DNA of the wild-type myoblasts by PCR and analyzed by Sanger 
sequencing. These sequences revealed that the mismatches were a result of 
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heterozygous SNVs at the sites in question in the wild-type sample. Thus, no 
candidate APOBEC2-dependent RNA editing events could be identified in the 
myoblast-derived mRNA-Seq data. 
Because miRNA-Seq data was also available, a similar comparison was 
made to check for APOBEC2-dependent editing in small RNAs. Although for 
some samples more unique C-to-T events were apparent in the wild-type sample, 
these were not consistent between replicates and appeared to be artifactual upon 
visual inspection (Table 3.3). 
 
3.8 Analysis of APOBEC2 RNA editing activity in adult murine muscle  
Experiments in the myoblast system failed to reveal a function for 
APOBEC2. Plausible issues with the myoblast experiments include the facts that 
the system is not physiological, or that APOBEC2 may act later than the 
induction of differentiation. Alternatively, the issue may have been with the 
experimental techniques and not the system itself. Examples of functions that 
could have been missed by the techniques used include editing of a long non-
coding RNA, editing of a low-expressed RNA, or a scaffold role for APOBEC2 in 
a complex that does not make use of its putative catalytic activity. 
 In order to comprehensively characterize any possible APOBEC2-
dependent RNA editing in physiological settings, directional, ribo-minus 
mRNA-Seq libraries were prepared from muscles from a pair of wild-type and 
Apobec2-/- adults. The three muscles used were chosen because they are classic 
examples of the easily accessible muscle types: the heart (cardiac), the extensor 
digitorum longus (fast-twitch skeletal), and the soleus (slow-twitch skeletal). The 
directional and ribo-minus library preparation conditions were chosen to  
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Table 3.3 Counts of apparent unique C-to-T SNVs (candidate editing events) in 
miRNA-Seq from wild-type and Apobec2-/- myoblasts. (IFPR = implied false 
positive rate) 
 
Comparison WT sites Apo2-/- sites IFPR 
d0 replicate 1 15 15 100% 
d0 replicate 2 15 15 100% 
d1 replicate 1 12 7 58% 
d1 replicate 2 15 14 93% 
d2 replicate 1 18 18 100% 




decrease the noise in identifying editing events due to incomplete annotations 
and to analyze non-polyadenlyated RNAs, respectively. 
Application of a similar RNA editing detection pipeline to that used on 
the myoblast samples again failed to identify any RNA editing events. No 
candidate events were identified in the wild-type soleus or EDL (as well as in the 
Apobec2-/- reciprocal comparison). For the heart, 59 candidate events were found 
in the wild-type compared to only 19 for the Apobec2-/- sample. While the counts 
alone were consistent with the existence of APOBEC2-dependent editing, nearly 
all of the events were located in regions of apparent non-isogenicity. The few that 
were from other genomic locations were found to be the result of mismapping 
upon visual inspection of the supporting reads. 
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Chapter 4. Investigation of 5-methylcytosine content of T. brucei DNA 
4.1 Motivation and preliminary findings  
 While DNA 5-cytosine methylation is best known as a silencing 
modification in mammals, the mark is used for a wide variety of other purposes 
in other organisms. For example, it is involved in regulating life cycle stages in a 
parasitic worm (Gao et al., 2012), in marking DNA for degradation in a ciliated 
protist (Bracht et al., 2012), and in setting caste identity in the honeybee (Elango 
et al., 2009; Wang et al., 2006). 
 In the unicellular eukaryotic parasite Trypanosoma brucei, 5-cytosine 
methylation is present in nuclear DNA, albeit at a lower level than in mammals 
(Militello et al., 2008). However its function in this organism, as well as the 
pattern of methylation within its genomic DNA, are unknown. As part of a study 
focused on another epigenetic mark in T. brucei, a colleague, Hee-sook Kim, had 
previously generated strains deficient in each of the 3 closest homologues of 
known 5-cytosine methyltransferase enzymes (henceforth CMT1, CMT2, and 
CMT3). Although none of the mutants displayed decreased methylation in bulk 
as assayed by dot blot, this experiment verified that 5-methylcytosine was 
present in DNA at levels well above background. Because of my interest in 
cytosine methylation, I decided to undertake whole-genome bisulfite sequencing 
of T. brucei with the goal of producing the first map of methylation in this 





4.2 Identification of candidate methylated sites by whole-genome bisulfite 
sequencing  
Because the genome of T. brucei is small (25 Mb), whole-genome bisulfite 
sequencing was the obvious choice for assaying methylation. To determine 
whether whole-genome bisulfite sequencing was possible for the T. brucei 
genome, as well as to validate the alignment strategy, simulated bisulfite-
converted reads were generated from a standard genome (427 strain) and then 
aligned back with Bismark. This resulted in 77.6% of simulated 50bp reads 
aligning uniquely, with only 15.6% of sites left completely uncovered. This was 
taken as evidence that the T. brucei genome was sufficiently complex to allow for 
efficient mapping of 50bp bisulfite-converted reads. 
 Libraries were prepared from wild-type genomic DNA from both the 
bloodstream form (BF) and procyclic form (PF) of wild-type 427-strain T. brucei, 
and the BF of CMT1-/- and CMT2 and CMT3 knockdown strains. Although none 
of the mutants had displayed decreased methylation in bulk, libraries were still 
prepared from both in case either was responsible for methylation of a particular 
subset of cytosines, as is the case in Arabidopsis (Lister et al., 2008). As a control 
for library preparation and mapping, an unconverted wild-type BF sample was 
run in parallel. 
Unmethylated lambda phage DNA was added to the genomic DNA prior 
to library preparation to serve as a positive control for bisulfite conversion. 
Genomic DNA was fragmented by sonication, repaired, ligated to sequencing 
adapters, bisulfite converted twice, and amplified by PCR. 
Once the sequencing data was in hand, test alignments were performed to 
determine the optimal genome configuration in terms of maximum number of 
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reads aligning uniquely. The BF sample was mapped to each permutation of the 
927-strain genome (for which genomic sequence is more complete, but belonging 
to a related strain and thus containing a number of sequence differences) or 427-
strain (which is less complete but corresponds to the genomic DNA actually used 
here) with or without a supplementary file containing known VSGs and 
repetitive elements. While all 4 of these options performed acceptably well, the 
best performing was 427 with VSGs, which yielded 43.4% of reads aligning 
uniquely. While this is much lower than the mapping efficiency for the simulated 
reads (77.6%), this is expected due to the repetitive sequences, and polymerase 
and sequencing errors that the simulation does not account for. 
After aligning all of the reads to the 427+VSG genome, apparent 
methylation levels were checked for the phage genome to verify that bisulfite 
conversion proceeded efficiently. For the converted libraries, the fraction of 
phage cytosines uncoverted ranged from 0.1-0.6%, while for the unconverted 
library it was 99.8%. Thus the background error due to incomplete bisulfite 
conversion, mismapping, and incorrect demultiplexing is less than 0.6%. 
Genomic coverage was then visually inspected with IGV. This revealed 
that for the bisulfite converted libraries coverage was “lumpy,” with sharp peaks 
as well as large stretches of zero coverage present. In contrast, the unconverted 
control displayed much more uniform coverage. Quantification of the 
theoretically mappable but uncovered (“anomalously uncovered”) regions of the 
genome revealed that it was much higher for the bisulfite-converted samples 
(13.7-13.9%) than for the uncoverted sample (2.1%) as well as the ideal Poisson-
distributed case (<0.1%). Comparison of the anomalously unmapped regions for 
the BF and PF samples revealed that they frequently overlapped (61% overlap 
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observed, with 14% expected if these bases were randomly distributed). 
Additionally, these anomalously uncovered regions had significantly lower CG-
content than covered regions (41.7%, compared to 47.4% for covered regions). 
Taken together, this suggests that the coverage pattern displayed in the bisulfite 
converted samples was a result of the properties of the bisulfite converted 
sequences themselves, perhaps as a result of preferential amplification of CG-rich 
sequences, and not a failure of the mapping strategy or insufficient number of 
raw seqeunces. This shortcoming could likely be fixed in the future by use of a 
PCR-free library preparation strategy. 
Bulk-level analysis of the methylation levels was then performed on the 
mapped reads. For each of the bisulfite-converted samples, the apparent 5mC/C 
ratio was 0.2-0.4%. These values are well within the range of background, and 
are much lower than was expected based on the initial 5mC dotblots.  
Despite the imperfect coverage and the surprisingly low levels of overall 
cytosine methylation, the sequencing data were analyzed to identify methylated 
cytosines. For each site, the binomial test was performed with the probability of 
success equal to the background uncovered percentage for that sample as 
determined by analysis of the unmethylated phage control. The resulting p 
values were then adjusted with the Benjamini-Hochberg method, and sites with 
q values < 0.05 considered candidate methylated sites. These candidate sites 
were few in number and were mostly derived from a few discrete genomic 
locations (Table 4.1). Visual inspection of the candidates revealed that most of 
these locations displayed hallmarks of mismapping, such as non-bisulfite-type 
mismatches nearby, or all of the methylation-supporting bases occurring at the  
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Table 4.1. Sites with significant levels of unconverted cytosine, as determined by 
the binomial test. Values for each library are apparent percentage methylated. 
Sites in orange are located in the 177-base pair repeat. 
site BF PF CMT1 CMT2 CMT3 BF_unconv 
Tb427VSG-999904:11 5% 0% 1% 1% 3% 99% 
Tb427VSG-999904:81 4% 2% 2% 3% 5% 100% 
Tb427VSG-999904:142 14% 29% 10% 19% 0% 97% 
Tb427VSG-999904:188 5% 2% 2% 4% 5% 99% 
Tb427_01_v4:93 19% 23% 19% 19% 19% 35% 
Tb427_01_v4:623754 0% 0% 33% 0% 0% 100% 
Tb427_01_v4:1061477 29% 63% 33% 61% 67% 45% 
Tb427_01_v4:1061479 100% 100% 100% 100% 100% 100% 
Tb427_01_v4:1061485 100% 100% 100% 100% 100% 100% 
Tb427_01_v4:1061486 100% 100% 99% 100% 100% 100% 
Tb427_01_v4:1061489 100% 100% 99% 100% 100% 100% 
Tb427_01_v4:1061492 100% 100% 100% 98% 100% 100% 
Tb427_01_v4:1061495 100% 100% 100% 100% 100% 100% 
Tb427_05_v4:1470913 18% 36% 0% 50% 0% 100% 
Tb427_08_v4:26469 33% 12% 29% 31% 28% 0% 
Tb427_09_v4:2240282 25% 15% 28% 14% 9% 100% 
Tb427_09_v4:2240286 25% 15% 26% 13% 9% 100% 
Tb427_09_v4:2240416 26% 6% 23% 11% 29% 100% 
Tb427_09_v4:2240417 26% 6% 23% 11% 29% 100% 
Tb427_09_v4:2240418 26% 7% 25% 11% 25% 100% 
Tb427_09_v4:2240426 25% 13% 33% 13% 28% 100% 
Tb427_09_v4:2240429 29% 13% 38% 15% 28% 100% 
Tb427_09_v4:2240430 29% 12% 43% 17% 28% 100% 
Tb427_09_v4:2240433 31% 13% 55% 22% 25% 100% 
Tb427_09_v4:2240435 36% 13% 55% 22% 31% 100% 
Tb427_09_v4:2240436 36% 14% 55% 13% 31% 100% 
Tb427_09_v4:2240440 36% 20% 67% 25% 31% 100% 
Tb427_09_v4:2240442 31% 21% 67% 25% 31% 100% 
Tb427_09_v4:2240450 33% 18% 71% 20% 40% 100% 
Tb427_09_v4:2240451 25% 20% 67% 0% 33% 76% 
Tb427_10_v5:449 4% 0% 1% 3% 18% 0% 
Tb427_10_v5:125988 4% 9% 6% 5% 6% 100% 
Tb427_10_v5:4057088 83% 86% 83% 88% 87% 91% 
Tb427_10_v5:4057096 88% 93% 94% 91% 91% 100% 
Tb427_10_v5:4057098 67% 81% 76% 79% 82% 89% 
Tb427_11_01_v4:640 50% 54% 49% 50% 50% 58% 
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site BF PF CMT1 CMT2 CMT3 BF_unconv 
Tb427_11_01_v4:2960 16% 25% 50% 29% 19% 0% 
Tb427_11_01_v4:530862 7% 16% 25% 15% 0% 100% 
Tb427_11_01_v4:1127249 8% 11% 7% 8% 5% 100% 
Tb427_11_01_v4:4125370 5% 5% 3% 10% 3% 100% 
Tb427_11_01_v4:4633063 89% 89% 91% 87% 89% 94% 
Tb427VSG-1494:687 0% 18% 14% 36% 14% 100% 
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end of reads. The exception to this was sites within the 177-base pair repeat, an 
element found in the minichromosomes of T. brucei (Sloof et al., 1983).  
 
 4.3 Validation of candidate methylated sites by methylated DNA 
immunoprecipitation  
To determine whether the 177-base pair repeat was truly methylated, I 
attempted to validate the bisulfite result by an orthogonal technique: methylated 
DNA immunoprecipitation. In this technique, DNA is immunoprecipitated with 
an antibody specific for 5mC and target regions are compared to input or to an 
isotype control by quantitative PCR. 
Genomic DNA was sonicated to an average size of 500bp and 
immunoprecipitated with a monoclonal anti-5mC antibody or an isotype control. 
As a control, mouse tail-tip DNA was immunoprecipitated in parallel. 
Two sets of primers to specifically amplify the 177-base pair repeat along with 
two sets of primers to amplify separate well-covered areas that had no 
methylated basecalls were designed and successfully tested for specificity on the 
sonicated DNA. Mouse DNA was analyzed at known methylated (H19) and 
unmethylated (Actb) loci. These primers were used for SYBR Green real-time 
PCR on the immunoprecipitated DNA.  
 In the mouse positive control, the methylated sequence was clearly 
enriched in the IP sample, with an enrichment of about 50x relative to the 
unmethylated amplicon (Figure 4.1). There was an even more dramatic 
enrichment in comparison to the isotype control, with so little DNA 
immunoprecipitated that real-time amplification failed. However for both T. 
brucei samples, an apparent disenrichment of the 177-bp sequences was observed  
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Figure 4.1. Validation of apparently methylated sites by MeDIP-qPCR. 
Enrichment was calculated relative to known unmethylated regions and (A) 
input or (B) isotype control IP. Values are averages for 2 sets of primers each for 
177-bp repeat and unmethylated regions. (177-1 and -2 = amplicons spanning the 
177-bp repeat, NC-1 and -2 = amplicons spanning unmethylated negative control 
regions, BF = bloodstream form, PF = procyclic form, Mm = Mus musculus)  
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in the IP relative to both input and isotype control. Relative to input as well as to 
isotype IP, the 177-bp repeat sequences appeared to be at least 10-fold less 
abundant than the sequences used as negative controls. A simple lack of 
enrichment would be interpretable as a lack of methylation at the 177-base pair 
repeat, but the magnitude of the apparent disenrichment suggests that the 
situation is more complex. It is possible that the sequences used as negative 
controls contain modified bases that cross-react with the 5mC antibody.  
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Chapter 5. Discussion‡ 
5.1  Refined model of AID activity in B cells 
 The genome-wide analyses of AID-dependent changes in gene expression 
and DNA methylation allow for a reexamination of the various activities that 
have been ascribed to AID in the B cell. The most obvious of these is the 
requirement of AID for CSR, which was made apparent by the presence of 
secondary-isotype-derived productive transcripts in the AID–miR-155T and 
wild-type samples and their absence in the Aicda-/- sample. Additionally, the 
increase in secondary isotype transcript levels in the AID–miR-155T sample 
compared to wild-type reconfirms the positive correlation between AID levels 
and levels of CSR (Teng et al., 2008). As has been previously discussed (Wang et 
al., 2009), this suggests that under physiological conditions the AID system is not 
optimized for maximum CSR, and so there is likely a tradeoff between CSR and 
off-target AID activity that maintains an intermediate level of the protein. 
 The second known physiological role for AID, initiating somatic 
hypermutation (SHM), is unfortunately not amenable to the analyses described 
here. This is due to two factors: cell type and sequencing technology. Attempts to 
detect elevated levels in mismatch rate at V-segments in the wild-type and AID–
miR-155T samples failed. This was not surprising, given the low levels of SHM in 
ex vivo stimulated naïve B cells and the sequencing error rates for the Illumina 
HiSeq platform. The likely bias towards correctly mapping unmutated V(D)J-
derived reads more frequently than mutated ones would further confound any 
conversion of mRNA-Seq data into a true SHM rate. It should however be 
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possible to directly examine levels of SHM by mRNA-Seq given a system in 
which these levels are higher (for example, germinal center B cells, with a 
transgenic BCR, after immunization), and perhaps greater sequencing depth 
and/or accuracy. 
 Although the mRNA-Seq results were consistent with the known 
“classical” functions of AID, the analyses failed to detect any signs of the known 
off-target effects of AID in B cells. For the well established AID-catalyzed 
hypermutation of certain non-Ig loci (Liu et al., 2008; Pasqualucci et al., 1998; 
Shen et al., 1998; Yamane et al., 2010), this lack of evidence was not surprising. 
The challenges of using mRNA-Seq to quantify SHM would present an even 
greater problem for detecting mutation of non-Ig targets, given their much lower 
mutation rate. 
 However, it is somewhat surprising that the DNA damage caused by AID 
does not display greater effects on the transcriptome or DNA methylome. 
Despite the known broad occupancy of AID in the genome (Liu et al., 2008; 
Yamane et al., 2010) and occurrence of AID-dependent translocations (Klein et 
al., 2011; Ramiro et al., 2004; Robbiani et al., 2009), there was no clear 
upregulation or promoter demethylation of DNA repair genes in the AID-
containing samples. There are a number of non-exclusive explanations for these 
observations. First, it is likely that off-target AID-dependent damage is rare in 
absolute terms. Previous reports have estimated the frequencies of AID 
deamination of its most frequent non-Ig target at 10-4 per basepair, and at of one 
of the most common AID-catalyzed translocations at 4 x 10-7 per wild-type cell 
(Robbiani et al., 2009). While this level of damage can have clear effects at the 
organismic level over time, as in the c-myc/IgH translocation in Burkitt’s 
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lymphoma, this sort of selection-dependent effect would not be apparent in the 
naïve culture system used here. 
 Another possibility is that the repair of AID-dependent DNA damage 
does not require a large transcriptional response. The fact that AID-dependent 
abundance differences are apparent for Ig isoforms, but not for the other genes 
known to play a role in CSR such as RPA (Chaudhuri et al., 2004) and Spt5 (Pavri 
et al., 2010) indicates that this is at least partly the case. It is possible that B cells 
are primed to deal with such widespread DNA damage without requiring a 
dynamic transcriptional response. The view that B cells are at least somewhat 
primed to perform error-free DNA repair is supported by the finding that 
constitutive AID expression leads to tumors in non-B cell types (Okazaki et al., 
2003). 
 Finally, it is possible that AID-dependent damage does elicit an 
appreciable population-level transcriptional response, but in a narrower 
population than the one sequenced here. It is possible that sequencing of a more 
uniform population in terms of AID induction or cell cycle phase may reveal 
such an AID-dependent upregulation of DNA damage response genes. 
A clear limitation of the work presented here is that none of the analyses 
are direct measurements of the frequency of off-target AID activity or AID 
occupancy in the genome per se; use of a more physiological system, such as 
germinal center B cells after immunization, may be able to yield more 
quantitative answers about the frequency and consequences of off-target AID 
activity. However it is clear that for the subset of cells studied here the only 
observable transcriptional consequences of AID at the population level are at the 
Ig loci despite its ability to act at many places in the genome. 
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5.2 Reconciliation of AID activity in B cells and other systems 
Despite previous data showing AID occupancy throughout the genome 
(Yamane et al., 2010) and DNA demethylation concurrent with B cell activation 
(Shaknovich et al., 2011), no AID-dependent demethylation events were 
observed in activated B cells, even when AID is overexpressed. This is in contrast 
to observations of AID-dependent demethylation in iPS cells (Bhutani et al., 2013; 
Kumar et al., 2013), primordial germ cells (Popp et al., 2010), heterokaryons 
(Bhutani et al., 2010), neurons (Guo et al., 2011), and zebrafish embryos (Rai et 
al., 2008). Three classes of explanations are possible to explain this difference: (1) 
that AID-dependent DNA methylation is cell-type specific and does not occur in 
B cells, (2) that AID-dependent DNA methylation occurs in B cells, but was not 
detected by the assays used here, and (3) that AID-dependent DNA methylation 
does not occur at all. 
Perhaps the easiest explanation for the gap between the dramatic effects 
attributed to AID in more exotic systems and the limited changes observed in B 
cells is that the AID-dependent demethylation pathway is cell-type specific. It is 
possible that AID does not catalyze DNA demethylation at all in B cells because 
cofactors required for AID-dependent DNA demethylation are not present in B 
cells, or alternatively B cells could possess some other factor that prevents 
deleterious demethylation in the presence of AID. The latter seems more likely 
than the former, given the expression in B cells of the two alleged cofactors of 
AID required for DNA demethylation, Gadd45 and TDG (Rai et al., 2008) and the 
known deleterious effects of AID expression in other cell types (Okazaki et al., 
2003). While no candidate that could act as such a cofactor has been identified, 
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there is precedent for altered treatment of AID-induced damage, which appears 
to be responsible for the varying error rates of repair at different loci (Liu et al., 
2008). 
There are also a number of circumstances that would lead to AID-
dependent DNA methylation that is undetectable by RRBS. For example, it is 
possible that AID-dependent DNA demethylation occurs at a subset of sites that 
are not covered by RRBS, such as CpG-poor regions of the genome. This 
possibility could be investigated by use of WGBS on the existing samples. 
Alternatively, AID-dependent demethylation in B cells could be obscured by 
rapid re-methylation, for example by DNMT1. However if this is the case, it is 
unlikely to be physiologically meaningful even if it were to be observable. 
Finally, it is possible that the differences are so small in number and magnitude 
that they are simply below the limit of detection of the RRBS technique. While it 
is clear that there is no difference in bulk levels of methylation between the 
samples, it is possible that a subset of the observed differences that are consistent 
with noise are biologically meaningful. Increased sequencing depth and 
sequencing of replicates would provide information about this possibility, but it 
is impossible to eliminate completely. 
Finally, there are reasons to doubt the existing reports of AID-dependent 
demethylation in mouse cells. One particularly concerning issue regarding 
publications that have found differences in methylation between cells from  
Aicda-/- and wild-type mice in reprogramming contexts (Kumar et al., 2013; Popp 
et al., 2010) is that they make use of an Aicda- allele that is on a C57BL/6 x CBA 
F1 background (Muramatsu et al., 2000) that has been backcrossed for many 
generations to C57BL/6. This is a concern here because the AID locus is in close 
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proximity to the locus of Nanog, a key factor in reprogramming to pluripotency. 
It is clear from both the distribution of SNVs in the mRNA-Seq data reported 
here and the observations of others (Hogenbirk et al., 2013) that the CBA-like 
region encompasses the Nanog locus. Reprogramming efficiency is known to be 
highly strain-dependent (Schnabel et al., 2012), and it is possible that the 
differences attributed to AID-deficiency were actually the result of differences 
between NanogC57BL/6 and NanogCBA. 
Furthermore, there are aspects of the reports of the AID’s influence on 
reprogramming that call their authors’ conclusions into question. Other 
laboratories have observed no effect of AID deficiency for reprogramming 
experiments using both Yamanaka factors (Habib et al., 2014) and heterokaryon 
formation (Foshay et al., 2012). While these differences do not invalidate the 
original reports, they do suggest that the effects attributed to AID are not robust.  
There are also reasons to suspect that the evidence for AID-dependent 
demethylation from lower vertebrates is not generalizable to mammals. In 
zebrafish, identical methylation phenotypes were observed when Aid, Apobec2a, 
or Apobec2b were knocked down (Rai et al., 2008). Because mammalian AID and 
APOBEC2 clearly behave very differently in terms of in vitro activity (Bransteitter 
et al., 2003; Chaudhuri et al., 2003; Dickerson et al., 2003; Mikl et al., 2005) and 
knockout phenotype (Muramatsu et al., 2000; Sato et al., 2010), it is difficult to 
imagine a situation where they would be interchangeable, as appears to be the 
case in zebrafish.  
Most significantly, the viability of the Aicda-/- mouse suggests that any 
possible role that AID plays in the regulation of DNA methylation is relatively 
modest. In contrast to the embryonic lethal phenotypes for the knockouts of bona 
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fide regulators of DNA methylation such as Dnmt1 (Li et al., 1992), Dnmt3a 
(Kaneda et al., 2004), Tet1 (Yamaguchi et al., 2013), and Tet3 (Gu et al., 2011b), 
Aicda-/- mice have no apparent defects in fertility, size, or health outside of the 
expected immune deficiencies. The similar phenotype of humans lacking AID 
(Revy et al., 2000) suggests that this is generally true of AID’s role in mammals.  
A consolidated explanation for the observations relating to AID and DNA 
demethylation would be as follows: in B cells, even though AID activity is 
widespread, AID-induced DNA damage does not lead to DNA demethylation 
because B cells possess a DNA repair system that leads to faithful transmission of 
methylation state. In reprogramming by iPS and heterokaryon formation, AID-
induced DNA damage can rarely lead to DNA demethylation due to differences 
in cofactors or available substrates. This demethylation is more likely to occur by 
deamination of nearby C and long-patch-type repair than by direct deamination 
of 5mC because of AID’s strong preference for the unmodified base (Larijani et 
al., 2005; Morgan et al., 2004; Nabel et al., 2012; Wijesinghe and Bhagwat, 2012).  
 
5.3 RNA-Seq strategies for characterizing B cell populations 
In addition to confirming a narrow role for AID action in B cells, the 
analyses presented here also demonstrate the broad capabilities of high 
throughput RNA sequencing. In addition to its standard usage as a gene 
expression assay, its utility in detecting RNA editing, CSR frequency and VH 
segment usage demonstrate its flexibility as a tool for characterizing populations 
of B cells.  
Although not performed on the data here, mRNA-Seq has the capacity to 
assay mutation rates. With improved depth, and when used on a system with 
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higher mutation rates, RNA-Seq may be a useful tool for assessing AID-
dependent mutation genome-wide. As the most comprehensive data to date 
regarding AID-catalyzed non-Ig hypermutation still only cover about a hundred 
loci (Liu et al., 2008), use of very deep RNA-Seq on B cells from immunized mice 
could lead to a much more complete picture of AID’s off-target activities. This 
same sequencing data could be useful in identifying AID-dependent 
translocations in a truly wild-type context by finding recurrent fusion-derived 
reads (Kim and Salzberg, 2011). 
 
5.4 Potential roles for APOBEC2 
 The clearest conclusion that can be drawn from the data presented here is 
that APOBEC2 is not likely to be an RNA editor. In both differentiating 
myoblasts and mature muscle tissue, no such activity could be observed. While I 
cannot exclude the possibility that it edits a very rare transcript or a common 
transcript at a very low level, it is also unlikely that such activity, should it exist, 
has physiological significance.  
While the data presented do not demonstrate a role for APOBEC2, they do 
help to clarify its possible activities. It remains possible that APOBEC2 has a 
function in DNA demethylation during muscle development. The observations 
of expression differences at known methylation-regulated genes between wild-
type and Apobec2-/- samples supports this, as do the impaired DNA 
demethylation phenotype observed in Apobec2a/b morphant zebrafish (Rai et al., 
2008). However, APOBEC2’s lack of enzymatic activity on DNA in vitro (Mikl et 
al., 2005; Nabel et al., 2012), and cytoplasmic localization (Etard et al., 2010) argue 
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against APOBEC2-mediated DNA demethylation. If APOBEC2 does function as 
a DNA demethylase in mammals, this activity must not be essential. 
 Alternatively, it is possible that mammalian APOBEC2 is not a cytidine 
deaminase at all, despite the clear conservation of its cytidine deaminase catalytic 
domain throughout evolution (Conticello, 2004). The lack of enzymatic activity in 
vitro and failure to find a substrate in vivo has led previous researchers in the 
field to suggest this possibility (Sato et al., 2010; Vonica et al., 2011), and the data 
presented here gives little reason to argue. APOBEC2 could have a structural 
function, or perhaps could catalyze deamination of a non-C substrate. Its 
enzymatic activity may also differ between species. While there is evidence that 
it serves a deamination-dependent function in lower vertebrates, it may have lost 
this activity in the mammalian lineage, which would explain the divergent 
phenotypes of APOBEC2-deficiency for zebrafish and mouse. Future studies of 
the proteins and/or nucleic acids that directly interact with APOBEC2 will likely 
be helpful in illuminating the function of the most obscure of the APOBECs. 
 
5.5 DNA cytosine methylation in T. brucei 
 The failure of whole-genome bisulfite sequencing to identify methylated 
sites in the T. brucei genome can be explained in two nonexclusive ways: that 
flaws in the experimental or analytical techniques prevented detection of 
methylation, or that this methylation does not exist.  
 One clear issue with the WGBS data described here is the poor genomic 
coverage of AT-rich regions. It is possible that all of the methylated sites in the T. 
brucei genome are located in AT-rich areas, and thus were not identified because 
they were not covered. Improved coverage could be achieved in future studies 
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by use of PCR-free library preparation protocols. Biases inherent in PCR have 
been shown to be the driving force in AT-content bias in library preparation 
(Aird et al., 2011), and PCR-free library preparation strategies have been shown 
to dramatically correct this bias (Kozarewa et al., 2009; Miura et al., 2012). 
 Even if ideally distributed coverage were attained, the ability to 
discriminate between methylated and non-methylated sites depends on the 
depth of coverage. If methylation occurs at low frequency, extremely high levels 
of coverage would be required to identify the methylated sites. While 10x 
average coverage would be more than sufficient for identification of methylated 
sites for a mammalian-like methylation landscape, it is impossible to know what 
levels of coverage are required for T. brucei without some prior knowledge of the 
distribution of methylated sites. 
Another complicating factor in the interpretation of WGBS data in T. 
brucei is the status of the genome. If methylated sites are located in regions that 
are difficult to assemble (such as repetitive sequences) or that differ between 
strains, these sites would be invisible to the strategy employed here. However, 
the extremely low frequency of C in reads that fail to map suggests that 
discordance between reference genome and genome of the sample is not the 
driving factor that prevented detection of methylation. 
 Finally, bisulfite sequencing in T. brucei is further complicated by the 
presence of beta-d-glucopyranosyloxymethyluracil, or base J, in genomic DNA. 
While there appears to be no study of the reactivity of bisulfite towards J, there is 
precedent for 5-oxidized pyrimidines forming stable adducts with bisulfite that 
are poor substrates for PCR (Huang et al., 2010). If J behaves similarly to 5hmC in 
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terms of bisulfite reactivity, coverage of J-rich regions may be impossible by 
bisulfite sequencing. 
 While there are many reasons why WGBS as deployed here could have 
failed to identify methylation, it is also possible that such methylation does not 
exist at all. The evidence that 5mC occurs in T. brucei DNA comes from two dot-
blot experiments, which both found that trypanosome genomic DNA bound anti-
5mC antibody more than Dcm- E. coli genomic DNA (Militello et al., 2008) and 
(H.-S. Kim, unpublished data). While the 5mC antibody is clearly not reactive 
towards C or any other base found in mammalian DNA, it remains possible that 
it crossreacts with some metabolite or other base found in T. brucei. It is also 
known that the antibody used is reactive towards 5mC in RNA. Although an 
RNAse A-treated control was performed with indistinguishable levels of signal, 
it is possible that the treatment conditions were insufficient to remove 
contaminating methylated RNA. 
Although no 5mC signal was observed in Dcm- E. coli DNA, it is possible 
that the differences in DNA extraction procedures or chromosome sizes between 
the E. coli and T. brucei samples led to differences in background that were 
interpreted as positive signal. One such source of background could be the 
presence of serum. Although almost none of the reads that fail to map to the T. 
brucei genome map to the B. taurus genome, if such fragments are very small they 
may have been excluded from the library preparation process. 
If it is the case that cytosine methylation is absent or very rare in T. brucei, 
it raises the question of what the identified putative CMT have as substrates. 
Because T. brucei has appreciable levels of 5mC in tRNA (Militello et al., 2014), it 
is likely that at least one of these CMTs acts on RNA. Techniques such as Aza-IP 
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(Khoddami and Cairns, 2013) could be a fruitful way to match these CMTs to 
their RNA substrates. 
 
5.6 Closing remarks 
 Although the work presented here provides a number of directions for 
future study. Perhaps the most obvious space for such work is the gap between 
AID’s apparent behavior in mouse B cells and iPS. Paired wild-type/knockout 
genome-scale methylation studies in cells undergoing reprogramming could be 
useful in assessing precisely how AID produces its methylation phenotype. In 
vitro characterization of AID from different species with respect to activity 
towards modified cytosines may also clarify the divergent phenotypes of AID 
deficiency in mammals and fish.  
 With respect to APOBEC2, the failure of pure sequencing methods to find 
a substrate suggests that looking first for interacting molecules may be a more 
fruitful approach. Mass spectrometry should allow clarification of APOBEC2’s 
interacting proteins, and ChIP or CLIP would allow identification of interacting 
nucleic acids even if they are not themselves edited. In vitro experiments using 
Apobec2 from zebrafish and mice may reveal the reason for the large difference 
in its importance between species. 
 The T. brucei results reported here suggest a clear way forward for 
characterizing this organism’s methylome: PCR-free WGBS. By solving the issue 
of uneven coverage, this technique should allow for a high-resolution map of 
DNA methylation, or make it clear that it does not exist. Once this map is 
established, the details of how methylation is regulated and what role it plays in 
T. brucei could be a rich field of study.   
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Chapter 6. Materials and methods 
6.1  Mice 
All C57BL/6 wild-type, Aicda-/- (Muramatsu et al., 2000), and AID-
miR155T (Teng et al., 2008) were used at 6-8 weeks of age for B cell experiments. 
C57BL/6 wild-type and Apobec2-/- (provided by L. Chan, Baylor College of 
Medicine) were used at 10-12 days of age for primary myoblasts. All mice were 
bred and maintained under specific pathogen-free conditions at the Rockefeller 
University Animal Care Facility and all procedures involving mice were 
approved by The Rockefeller University Institutional Animal Care and Use 
Committee. 
 
6.2  Cell culture 
6.2.1  B cells 
Mice were euthanized by cervical dislocation and spleens removed. The 
spleens were crushed with a syringe plunger in a cell strainer in a 6cm dish with 
5 mL cold 1x PBS, and the flowthrough pipetted vigorously and spun at 1500 
rpm for 4’ at 4ºC. The resulting pellet was resuspended in 1 mL 0.16M NH4Cl in 
water and incubated 5’ at RT to lyse red blood cells. This solution was underlaid 
with 1 mL FBS and spun 1500 rpm for 5’ at 4C. The resulting pellet was washed 
twice with 1x PBS with 10% FBS, resuspended in 2.5 mL PBS with 10% FBS, and 
counted with a hemocytometer. Cells were then resuspended in 90 µL PBS with 
0.5% BSA and 10ul anti-CD43 MACS beads (Miltenyi Biotec) per 107 cells. This 
mixture was incubated 15’ in refrigerator, then applied to an LS magnetic column 
(Miltenyi Biotec) that had been prewashed with 3mL 1x PBS with 0.5% BSA and 
	  102 
2mM EDTA. The column was eluted with 3.5 mL 1x PBS with 0.5% BSA and 
2mM EDTA, and the cell count in the eluent determined with a hemocytometer. 
The cells were then centrifuged and resuspended at 106 cells per mL in pre-
heated RPMI with glutamine (Gibco) supplemented with 1x Pen/strep (Life 
Technologies), 2 mM L-glutamine (Life Technologies) 10% FBS, 50 uM 2-
mercaptoethanol, 5 ng/mL IL-4 (Sigma), 1ul/mL monoclonal IgM a-CD40 
(Ebiosciences, clone HM40-3), and 25 µg/mL LPS (Sigma). The cells were 
cultured in 6-well plates at 37C and 5% CO2. Prior harvesting of nucleic acids for 
mRNA-Seq and RRBS, dead cells were removed by resuspending 107 cells in 100 
µL dead cell removal beads (Miltenyi), incubating 15’ at RT, adding 1 mL dead 
cell binding buffer, then applying to an LS column (Miltenyi) that had been 
prewashed with 3 mL dead cell binding buffer. The columns were then washed 
with 12 mL binding buffer and split into thirds for flow cytometry or lysis for 
DNA or RNA. 
 
6.2.2 Primary myoblasts 
Congenic 10-12 day-old C56BL/6 wild-type and Apobec2-/- pairs were 
euthanized by decapitation and muscles of the hind leg dissected. The muscles 
were pulped with scalpels in 1.25 mL of a collagenase/dispase solution (2.4 
U/mL dispase II [Roche], 1% collagenase B [Roche], 2.5 mM CaCl2) in a 35mm 
dish. This suspension was incubated 24’ at 37C and 5% CO2, pipetting 
thoroughly every 12’. PBS (2 mL) was added to the resulting slurry and filtered 
through a cell strainer inside of a 50 mL conical flask that had been pre-wet with 
1 mL 1x PBS. A further 7 mL PBS was used to wash the plate and strainer, and 
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the flowthrough moved to a 15 mL conical. This suspension was then pelleted 
(5’, 2000 rpm, 4C) and resuspended in 3 mL growth media (Ham’s/F10 media 
[Gibco] supplemented with 20% FBS, 2x Pen/strep [Life Technologies], 2.5 
ng/mL bFGF, 10 ng/mL HGF, and 5 ng/mL heparin sulfate [Sigma]). The cells 
were then plated onto an uncoated 60mm tissue culture dish and incubated at 
37C and 5% CO2 for 3h to allow fibroblasts to settle. The supernatant was then 
moved to a collagen-coated 60mm dish, and the replating procedure repeated the 
following day. Cells were expanded for 3 weeks and differentiated at 70% 
confluency by changing to differentiation media (DMEM [Gibco] supplemented 
with 1x Pen/strep and 5% horse serum [Gibco]). 
 
6.3 Flow cytometry 
For flow cytometric analysis of B cells, cells were pelleted (5000 rcm, 4C, 
30”), resuspended in 3 µL 7-AAD solution (BD), and incubated on ice 5’. The cells 
were then stained with 100 µL of FACS buffer (1x PBS with 1% FBS) along with 
1:200 IgG1-PE (BD) and 1:400 B220-APC (BD). The cells were incubated 5’ on ice, 
washed twice with 500 µL cold FACS buffer, and resuspended in 300 µL FACS 
buffer. For wild-type, Aicda-/-, and AID-miR155T B cells used for mRNA-Seq and 
RRBS, data was acquired on a FACSCalibur flow cytometer (BD). For 
retrovirally-complemented Aicda-/- B cells used for miRNA-Seq, data was 
acquired on a FACSAria cell sorter (BD), and singlet, 7-AAD-, B220+, GFP+ cells 





6.4 Retroviral infection 
For preparation of retroviral particles, 12 µg pCL-Eco and 12 µg pMX-GFP 
or pMX-AID-IRES-eGFP in 1.4 mL OptiMEM was mixed with 60 µL 
lipofectamine 2000 (Life Technologies) in 1.6 mL OptiMEM and incubated 20’ at 
RT. This mixture was added dropwise to a 10cm dish of 90% confluent 293T cells 
in DMEM (Gibco) with 10% FBS and 1x Pen/strep, and the cells then moved to 
an incubator. After 6h, media was changed to virus collection media (IMDM 
(Gibco) with 5% FBS and 1x Pen/strep). Media was changed and discarded at 
24h after transfection, changed and collected at 48h, and collected at 72h. The 
collected supernatant was spun 2’ at 1000 rcm to remove debris, filtered through 
a 45 um syringe filter, and stored at -80C until use. 
Aicda-/- B cells in culture for 1d were infected with retroviral supernatant 
supplemented with 8 µg /mL polybrene (1 mL retroviral supernatant per 106 
initial B cells), and spun 800 rcm, 10C, 2h. Cells were moved back to the 
incubator without changing media, and GFP expression was monitored by 
microscopy. 
 
6.5 Generation of RNA spikes 
ERCC spikes were the gift of C. Mason (MSKCC). VSG spikes were 
generated by K. Lay from pGEM-VSG constructs (contributed by G. Hovel-
Miner), and VSG* constructs, in which single C>T changes were introduced by 
mutagenesis PCR using Phusion polymerase. These constructs were linearized 
with SalI, gel-purified, and transcribed using the Mega T7 In Vitro Transcription 
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kit (Ambion). The resulting transcripts were precipitated, resuspended, and 
quantified using a Bioanalyzer RNA chip (Agilent). 
 
6.6 Generation of sequencing libraries 
6.6.1 mRNA-Seq 
For preparation of libraries from B cells and primary myoblasts, RNA was 
harvested by lysing cells in Trizol (Invitrogen) according to the manufacturer’s 
instructions, using 1 mL for 2 x 106 B cells or a 6 cm dish of myoblasts. Libraries 
were then prepared according to a protocol adapted from (Rosenberg et al., 
2011). Total RNA (10 µg) was selected twice with Sera-Mag oligo(dT) beads, and 
for the B cell libraries, ERCC (0.5 µL of 1:100 dilution per sample) and VSG spikes 
(50-300 pg/sample) were added. RNA was then chemically fragmented to a 
mode size of about 200 nt (4’ at 94C in 30 mM Mg2+), and precipitated. The 
fragmented RNA was then reverse-transcribed with Superscript III (Invitrogen) 
and random hexamer primers, and made double stranded with a mix of E. coli 
DNA polymerase I, E. coli DNA ligase, and RNAse H (all NEB). The ends of the 
double-stranded cDNA were then repaired with T4 DNA polymerase and T4 
polynucloetide kinase and adenylated with Klenow exo- (all NEB). These 
products were then ligated to Illumina TruSeq DNA adapters with T4 DNA 
Quickligase (NEB), and size-selected on a 2% agarose gel, taking fragments in the 
range 300-350 bp. These fragments were then enriched by PCR using Phusion 
DNA polymerase (NEB) for 15 cycles. Following validation using a Bioanalyzer 
Pico chip (Agilent), the libraries were sequenced (100-cycle, single-end) on an 
Illumina HiSeq 2000. 
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For preparation of libraries from muscle tissue, muscles were dissected 
and put immediately into 1.5 mL Trizol, then homogenized with a 5 mm stainless 
steel bead in a Qiagen TissueLyser LT at 50 Hz for 10’. Ribosomal RNA was 
depleted with the Ribo-Zero Gold Magnetic Human/Mouse/Rat kit (Epicentre) 
according to the manufacturer’s protocol. Directional RNA-Seq libraries were 
then prepared according to the manufacturer’s protocol using the NEBNext Ultra 
Directional RNA Library Prep Kit for Illumina, along with Illumina TruSeq DNA 
Adapter oligos, and sequenced on an Illumina HiSeq 2000 (100-cycle, single-end). 
 
6.6.2 miRNA-Seq 
Libraries were prepared by A. Mihailovic according to a published 
protocol (Hafner et al., 2012). Sequencing was performed on an Illumina HiSeq 
2000 sequencer (50-cycle, single-end). 
 
6.6.3 Reduced-representation bisulfite sequencing 
Libraries were prepared according to a protocol adapted from (Gu et al., 
2011a). DNA was harvested from 5 x 106 B cells per genotype with the DNeasy 
Blood and Tissue kit (Qiagen), according to the manufacturer’s instructions. The 
resulting genomic DNA (500 ng per sample) was digested with 2 µL MspI (NEB) 
for 18h and purified by phenol/chloroform extraction. Following end repair and 
adenylation, Illumina methylated adapter oligos were ligated to the products. 
Gel purification for products of size 200-350 bp was followed by two rounds of 
bisulfite conversion using the Qiagen Epitect kit. The resulting fragments were 
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enriched by PCR with Pfu Cx Hotstart polymerase (Agilent) and sequenced at 
low density on an Illumina HiSeq 2000 (50-cycle, single end). 
 
6.6.4 Whole genome bisulfite sequencing 
Whole genome bisulfite sequencing libraries were prepared according to a 
protocol adapted from (Johnson et al., 2012). Genomic DNA (3.2 µg per sample) 
was spiked 1:1000 with unmethylated phage DNA (Promega) and fragmented to 
an average size of 300 bp using a Covaris S2 sonicator. The fragmented DNA was 
then end-repaired, adenylated, and quantified using the Quant-iT reagents (Life 
Technologies) and a FLUOstar Omega fluorescence plate reader. Illumina TruSeq 
DNA Adapters were then ligated at a 10:1 molar ratio, and 2 rounds of bisulfite 
conversion were performed using the Qiagen Epitect kit. Resulting fragments 
were amplified with Pfu Turbo Cx Hotstart polymerase and size selected on a 2% 
agarose gel to yield fragments of size 375-475 bp. Resulting products were 
quantified with Quant-iT reagents and sequenced on an Illumina HiSeq 2000 (50 
cycle, single-end). 
 
6.7 Sequencing data analysis 
6.7.1 mRNA-Seq 
Following quality control inspection with FastQC 
(http://www.bioinformatics.babraham.ac.uk/projects/fastqc/), reads were 
aligned to the Ensembl reference transcriptome (release 63) supplemented with 
Igh transcripts with J1-4-C and I-C junctions explicitly added for each isotype, and 
then to the NCBI37 reference genome supplemented with ERCC and VSG 
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sequences. This was done using Tophat v2.0.3 (Kim et al., 2009a) and with the 
parameters “--b2-sensitive --no-novel-juncs”. Values for gene expression were 
calculated with Cuffdiff v.2.0.2 (Trapnell et al., 2010), using the Ensembl gene set 
supplemented with Igh transcripts and a masking file with annotated 
mitochondrial genes, rRNA and tRNA genes and pseudogenes. Values for Ig 
isotype abundance were calculated by dividing the sum of the FPKM values for 
J1-4-Cx for a given isotype by the sum of the FPKM values for all J1-4-C isoforms. 
For VH segment usage analysis, all mouse Ig segments listed in IMGT 
(Lefranc et al., 2009) were first aligned to chromosome 12 with Bowtie v0.12.7 
(Langmead et al., 2009). These alignments were then curated by manually 
inspected with IGV (Robinson et al., 2011).  
 
6.7.2 miRNA-Seq 
 Adapters were removed from sequence data using the script 
fastx_barcode_splitter.pl and two bases were trimmed from the 3′ end using 
fastx_trimmer, both from the FASTX-toolkit suite 
(http://hannonlab.cshl.edu/fastx_toolkit/). Trimmed reads were aligned with 
Bowtie v0.12.7 against NCBI37 using the parameters “-l 15 -v 2 --best --strata -m 
1”. The resulting hits that overlapped with sequences annotated in miRbase 







6.7.3  RRBS 
Following quality control inspection with FastQC, adaptors were 
sequentially trimmed from raw reads by using the program TrimGalore v0.2.2 
(http://www.bioinformatics.babraham.ac.uk/projects/trim_galore/) with the 
parameters “-a AGATCGGAAGAGC”, then “-s 8 -a CGGTTCAG”, then “-s 8 
AGCAGGAA”. Trimmed reads were aligned to the mouse genome (NCBI37) 
using Bismark v0.7.4 (Krueger and Andrews, 2011) with Bowtie v0.12.7 with 
parameters “-l 20”. Initial methylation counts were found using Seqmonk, and 
statistical analyses were performed using R. Each position was used for analysis 
if it was covered at least 10x for all of the samples, and features were used if they 
contained at least 3 such positions. Features were defined using the Ensembl 
reference. Promoters were defined as -5 kb to +1 kb from the reference TSS. 
 
6.7.4 WGBS 
Reads were aligned using Bismark v0.7.7 and Bowtie v0.12.7 with the 
parameters “-q -n 1 -k 2 --best --chunkmbs 512”. A custom genome was used for 
alignment, consisting of the following sequences: Tb427 v4 for chromosomes 1-9 
and 11, Tb427 v5 for chromosome 10, a composite BES site (“chromosome 12”), a 
curated set of VSG and repetitive sequences (G. Cross), the phage strain J02459_1 
genome, the phiX174 genome used for Illumina quality control, and the Illumina 
adaptor sequences. The number of C and T basecalls at every genomic C was 
then counted using Seqmonk, and bisulfite conversion efficiency calculated as 
the percentage of apparently methylated basecalls mapping to the phage 
genome. Candidate methylated positions were then identified by applying a 
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binomial test with chance of success set at the bisulfite conversion efficiency for 
that sample (in R, with the function binom.test). The resulting p values were 
adjusted for multiple testing using the Benjamini-Hochberg method (in R, with 
the function p.adjust with method=”BH”), and sites with q<0.05 in any sample 
were taken as candidates. 
 
6.8 Epityper assays 
Primers for use in the Epityper assay were designed using the Epidesigner 
tool (www.epidesigner.com). The assays were performed by the Weill Cornell 
Medical College Epigenomics Core.  
 
6.9 Targeted bisulfite sequencing 
 Genomic DNA from primary myoblasts was bisulfite converted with the 
Qiagen Epitect kit, then amplified with Hotstar Taq polymerase (Qiagen). 
Aliquots of each reaction were electrophoresed on an agarose gel to verify 
amplification, and then cloned using the Strataclone PCR cloning kit (Agilent) 
according to the manufacturer’s protocol. The ligation reaction was transformed 
into Strataclone Solopack chemically competent E. coli (Agilent) and plated on 
LB-agarose with ampicillin and X-gal. White colonies (10 per plate) were 
sequenced with the T3 primer by Genewiz. Resulting sequences were analyzed 
using the QuMA tool (Kumaki et al., 2008). 
 
6.10 Immunofluorescence imaging 
Primary myoblasts in 35 mm dishes were fixed in PBS with 4% 
formaldehyde and blocked in PBS with 1% BSA, 1% gelatin, 5% normal goat 
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serum, and 0.1% Triton-X. Cells were then stained in blocking buffer with 1:10 
mouse monoclonal a-MyHC (clone MF-20, DSHB, supernatant) and 1:50 rabbit 
polyclonal a-MyoD (M-318, SC760, Santa Cruz). After washing 3 times with PBS, 
secondary stain was performed in blocking buffer with 1:1000 goat a-rabbit 
Alexa Fluor 546, 1:1000 goat a-mouse Alexa Fluor 488, and 1:200 phalloidin-
Alexa Fluor 657. After 3 washes, cells were incubated with 1:1000 Hoescht in 
PBS, and a cover slip was mounted using Prolong Gold (Life). Images were 
acquired using a Zeiss Wide-field fluorescence/brightfield/DIC microscope. 
 
6.11 Western blotting 
Western blotting of primary myoblasts was performed by B. Rosenberg. 
One 60mm dish per condition was rinsed in 1x PBS, trypsinized, quenched, and 
pelleted before flash-freezing and storage at -80C. These pellets were lysed in 60 
µL RIPA buffer with cOmplete mini protease inhibitor (Roche) and PMSF for 20 
minutes at 4C and centrifuged at 12 krpm for 20 minutes at 4C. Following 
quantification of the supernatant using the Bradford assay, for each of two blots 
10 µg protein was diluted 1:1 with 2x Laemmli buffer with 200 mM DTT and 
incubated for 5 minutes at 95C. These samples were then electrophoresed on a 
Criterion 12.5% Tris-HCl gel (Bio-Rad) at 150V. Following wet transfer to PVDF 
membrane (100V, 30 minutes) and blocking (PBS with 0.1% Tween and 5% milk, 
2.5 hours at 4C), the following primary incubations were performed: 1:1000 of 
polyclonal rabbit anti-APOBEC2 (gift of Alin Vonica) in PBS with 0.1% Tween 
and 5% milk overnight at 4C; 1:250 of polyclonal rabbit anti-MyoD1 (Santa Cruz, 
M-318) 1 hour at room temperature. Following 4 washes (5 minutes, PBS with 
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0.1% Tween, room temperature), secondary incubation was performed with 
RG16 anti-rabbit HRP at 1:20000 in PBS with 0.1% Tween and 1% milk for 1 hour 
at room temperature. The membrane was then washed twice in PBS and 
visualized by ECL (1 minute exposure for APOBEC2, 4 minute exposure for 
MyoD1). 
 
6.12 Methylated DNA immunoprecipitation 
Immunoprecipitation of methylated DNA was performed according to a 
protocol adapted from (Mohn et al., 2009). Genomic DNA was fragmented to an 
average size of 500 bp using a Covaris S2 sonicator, then precipitated. After 
setting aside input samples, DNA was immunoprecipitated using Dynabeads 
sheep a-mouse IgG magnetic beads and mouse monoclonal a-5mC (Eurogentec 
clone 33D3) or mouse IgG1 isotype control antibody (Cell Signaling). DNA was 
digested from the beads with proteinase K and phenol/chloroform extracted. 
Quantitative real-time PCR was then performed using Sybr Green master mix 
(Life Technologies) and an ABI 7900 thermocycler.  
 
6.13  Primer sequences 
Below are the sequences of the primers used in the experiments described. 
 





Targeted bisulfite sequencing primers (Gtl2 primers from (Sato et al., 2011), 
















MeDIP primers (from (Weber et al., 2005)): 
177-1 F: GCGCAGTTAACGCTATTATAC 
177-1 R: CTTTGTTGCACACATTAAACAC 
177-4 F: GTGCAACAAAGCTAATAAATGGTTC 
177-4 R: CACACTTGTATTTAATGTTGCACACTTG 
Nc-1 F: TGAAATACTTAGGGTGACGGATG 
Nc-1 R: ATCCCTCTCCTCAACACAAATC 
Nc-2 F: TGTACGTGTCTGCTCGTTTG 
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Nc-2 R: TTCGGGTGGAGTCGGAA 
H19 F: GCATGGTCCTCAAATTCTGCA 
H19 R: GCATCTGAACGCCCCAATTA 
Actb F: AGCCAACTTTACGCCTAGCGT 
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